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ABSTRACT
Toxoplasma gondii is an intracellular parasite of humans in the phylum 
Apicomplexa. In an intermediate host (including human and other mammals), T. gondii 
occurs in an actively dividing form (tachyzoite) and a dormant form (bradyzoite). My 
research is focused on the function o f enolase, which is present in two isoforms known as 
ENOl and EN02. Previous study showed that enolase is expressed in stage-specific 
manner. EN02 is expressed only in tachyzoites, and ENOl is specifically expressed in 
bradyzoites. Moreover, both isoforms o f enolase are be localized in nucleus as well as in 
cytoplasm of T. gondii. This research is aimed to dissect the role o f EN 02 in the growth 
o f T. gondii. I used homologous dsRNA to induce ENOl or EN 02 gene silencing. I 
generated two transgenic parasite lines expressing ENOl or EN 02 dsRNA, and used 
them in the loss-of-function study. Although the reduction o f EN02 expression was 
observed, I did not detect any changes in the growth of parasites, as monitored by two 
different methods, vacuole counting and plaque assay. I postulated that another protein or 
other metabolic pathway might compensate for the loss o f EN 02 function.
iii
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CHAPTER 1 
INTRODUCTION
1.1 Toxoplasma gondii
Toxoplasma gondii is an intracellular pathogenic protozoa parasite. It belongs to 
the phylum Apicomplexa and is the only known member of the genus Toxoplasma. It was 
first discovered in a rabbit, by Splendore in Brazil in 1908, and also by Nicolle and 
Manceaux in a northern African rodent Ctenodactylus gundi (Black and Boothroyd, 
2000). As most o f the Apicomplexa parasites, T. gondii is an important pathogenic agent 
of humans and animals. Its hosts include the vast majority o f warm-blooded animals. In 
2000, it was reported that, 15.8% of the population between 12 to 49 years old in United 
States were infected with T. gondii (Jones et ah, 2003). The infection causes the disease 
called toxoplasmosis, which is usually asymptomatic in healthy individuals. However, for 
immuno-compromised patients, such as AIDS patients and those who have recently 
received organ transplantation, infection by T. gondii can cause severe complications 
such as hepatitis, pneumonia, blindness, and neurological disorders and may lead to 
behavioral alteration. Furthermore, an acute infection during pregnancy can cause in 
utero infection as well, resulting in a spontaneous abortion, a stillborn child, or a child 
that is bom with some degree of mental or physical retardation (Dubey, 1996).
While residing in the hosts, T. gondii converts between tachyzoite, the rapid 
proliferating stage, and bradyzoite, the slowly replicating stage. Normally, 
uncompromised host immune response can quickly remove tachyzoites during the acute
l
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infection. In most cases of human toxoplasmosis, tachyzoites can differentiate into 
bradyzoites, which stay within the tissue cysts. Parasites are thus able to escape the host 
immune response for the remainder of the host’s lifespan, leading to the chronic infection. 
When the patients become immuno-compromised, bradyzoites are released from the cysts 
and differentiate into tachyzoites, resulting in a recurrent acute infection (Gross et al.,
1996). Current treatment o f toxoplasmosis using a cocktail o f pulfonamide 
(dihydropteroate synthetase inhibitor) and pyrimethamine (dihydrofolate reductase 
inhibitor) is only effective for the acute infection and may cause harsh side effects (Black 
and Boothroyd, 2000). Although a combination o f atovaquone and clindamycin is 
effective for treatment o f the chronic toxoplasmosis in mouse and some other animals, 
their effects have not been re-produced in human (Alves and Vitor, 2005; 
Djurkovic-Djakovic et al., 2002). To develop new drug targets and strategies to eradicate 
its infection, we need to learn more about the parasite, especially its metabolism and 
interaction with host organisms.
1.1.1 Life cycle of T. gondii
Toxoplasma gondii multiplies by sexual and asexual cycles. The sexual life cycle 
occurs exclusively in the intestine of its definite host, felines. The cycle begins when a cat 
ingests food containing T. gondii-tissue cysts. The parasites are released from the cyst in 
the small intestine and infect epithelial cells, initiating gametogenesis and differentiation 
into micro- and macrogametes. Then, two gametes fuse and produce an oocyst, which is
2
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later secreted in feces. Millions of oocysts can be generated within 2 weeks after oocyst 
formation. Within 2-3 days after being released from the intestine, oocysts undergo 
sporogony and generate the infective haploid stage known as sporozoites. The mature 
sporozoites are very stable in the environment and can survive for months in cold and dry 
climates (Dubey, 1994). When the sporozoites are ingested by the felines, they continue 
to propagate by the sexual life cycle. Ingested by other animals, referred to intermediate 
hosts, the parasites will multiply using their asexual life cycle.
The asexual life cycle occurs in any infected warm-blooded animals. The 
transmission can usually begin following the ingestion o f sporulated oocysts or 
bradyzoites in tissues cysts in raw or contaminated meat products. Then the parasites 
transform into tachyzoites and reproduce asexually within infected cells. After several 
rounds o f synchronous division of the parasites, the infected cells that cannot support the 
parasite load will be destroyed. Newly formed tachyzoites are then released to infect 
other cells. During this phase of infection, the tachyzoites can spread to every organ of 
the host. Approximately 2-3 weeks following infection and in response to the host 
immunity, the tachyzoites convert to slow-replicating bradyzoites within the tissue cysts 
(Dubey et al., 1998; Soete et al., 1993).
3
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Figure 1.1 
Life cycle of Toxoplasma gondii 
Legend
The life cycle of T. gondii consists o f two phases: sexual and asexual. The sexual 
phase occurs only in the intestine o f felines (definite host) while the asexual phase takes 
place in birds and animals (Yang and Parmley, 1997). The figure is obtained from Black 
and Boothroyd, 2000.
4
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Figure 1.1 
Life cycle of Toxoplasma gondii
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Environment
1.1.2 Differences between tachyzoites and bradyzoites
The conversion between tachyzoites and bradyzoites is accompanied by 
morphological and molecular biological changes, including the expression of 
stage-specific antigen and the alterations of basal metabolism (Ferguson and Hutchison, 
1987; Denton et al., 1996).
The fast-growing tachyzoite is usually surrounded by a sac-like membrane, called a 
parasitophorous vacuole, which originates from both the host and parasite cell 
membranes (Gross et al., 1996). The tachyzoites within a single vacuole usually divide 
synchronously, leading to the formation of a rosette structure. The bradyzoites stay in the 
tissue cysts that can be as large as 100pm in length and are mainly localized in the brain 
and muscle tissues. The tissue cysts are surrounded by an elastic thin wall which contains 
P-(l, 4) linkaged N-acetyl-glucosamine residues called chitin without glycogen and other 
polysaccharides (Gross et al., 1996). The cyst wall is able to bind with lectins such as 
those found in the seed o f Dolichos biflorus and wheat-germ (Boothroyd et al., 1997; 
Tomavo, 2001; Cleary et al., 2002). Thus these lectins are used as the detection reagents 
for the tissue cysts and bradyzoites (Ferguson et al., 2002). Within the cyst wall, the 
bradyzoites are less susceptible proteolytic enzymes and gastric acid in the stomach 
(Freyre, 1995). Within the cytosol of the bradyzoites, several amylopectin granules are 
located and supposedly act as energy source. Having non-functional mitochondria, 
bradyzoites lack a functional TCA cycle and respiratory chain. As a result, bradyzoites 
are not susceptible to mitochondrion electron transport inhibitors such as atovaquone. On
6
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the other hand, tachyzoites have functional mitochondria and both aerobic and anaerobic 
respiration (Denton et al., 1996; Dando et al., 2001). Thus glycolysis is essential for both 
tachyzoites and bradyzoites. Therefore, the enzymes catalyzing the reactions in the 
glycolysis pathway, such as enolase, glucose-6-phosphate isomerases and 
glyceraldehyde-3-phosphate dehydrogenase, have been considered as promising drug 
targets in T. gondii and many other apicomplexa parasites (Verlinde et al., 2001; Roos, 
2005).
Differential expressions of heat shock proteins (HSP) were reported in the 
tachyzoite and bradyzoite stages. For example, two differentially spliced forms o f HSP60 
are present in both life cycle stages. Using polyclonal antibodies raised against HSP60, it 
was found that HSP60 is localized in the mitochondria in tachyzoite stage, while in two 
vesicular bodies during the stage of bradyzoites (Toursel et al., 2000). Bradyzoite specific 
antigen 1 (BAG1) or HSP30, which is homologous to small plant HSP, is only expressed 
in bradyzoites, but not in tachyzoites (Bohne and Roos, 1997; Parmley et al., 1995). In 
addition, many surface antigens, including CST1, SAG2A and SAG2B, are stage-specific, 
suggesting they might be important for the interaction between the parasites and their 
host cells (Zhang et al., 2001; Cleary et al., 2002; Lekutis et al., 2000). Moreover, a 
number o f metabolic enzymes, including those of glycolysis and gluconeogenesis such as 
lactate dehydrogenase (Dando et al., 2001), glucose-6-phosphate isomerases (G6PI) and 
enolase (ENO), were reported to be differentially expressed in tachyzoite and bradyzoite, 
suggesting that their association with changes in metabolism rates and environment
7
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adaptation o f the parasites (Yang and Parmley, 1997; Tomavo, 2001; Dzierszinski et al., 
2001; Dzierszinski et al., 1999).
1.1.3 Interconversion between tachyzoite and bradyzoite
The conversion between tachyzoite and bradyzoite is essential for T. gondii and 
plays a key role in its pathogenesis. A better understanding of the interconversion 
mechanism could greatly facilitate a design for new chemotherapeutic agents capable of 
eliminating tissue cysts (Boothroyd et al., 1997). In vivo, the stage conversion is related 
to the host inmmune responses. It has been suggested that the switch between tachyzoites 
and bradyzoites is related to the expression o f heat shock proteins and parasites’ stress 
responses.
Most experimental strains of T. gondii can switch between tachyzoites and 
bradyzoites in cell cultures. About 10-20% of cysts are formed by spontaneous 
conversion. External stresses mimicking the host immune responses can induce tissue 
cyst formation and increase the formation of cyst in vitro (Soete et al., 1993). The 
cyst-induction includes growing the parasites in the alkaline environment (pH 8.2-8.4) or 
acid conditions (pH 6.6-6.8), increasing culture temperature (42 °C instead of 37 °C). 
These methods rely on the stress response of the parasites (Soete et al., 1993; Weiss et al., 
1995; Weiss and Kim, 2000). Inhibitors o f mitochondrial function, such as oligomycin, 
antimycin A, atovaquone and rotenone, as well as inducers o f oxidative stress including 
nitric oxide and Nitroprusside, an exogenous source o f nitric oxide, can also induce the
8
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encystment of in vitro cultures (Soete et al., 1993; Bohne et al., 1994). It was also 
shown that the elevation o f cAMP or cGMP could play a role in the bradyzoite induction 
(Kirkman et al., 2001). Immunological factors, including interferon (IFN)-y and tumour 
necrosis factor (TNF)-a, play a role in controlling tachyzoite growth and could indirectly 
control stage conversion. Although evidence suggest the indirect effect of NO-induced 
stress, the underlining mechanism has yet been determined (Alexander and Hunter, 
1998).
Additionally, it was reported that conditions favouring the formation of bradyzoites 
were associated with the up-regulation of heat shock proteins (HSPs), suggesting that 
HSPs are essential during stress-induced stage conversion (Weiss et al., 1998). Knockout 
o f the BAG1 {HSP30) gene can decrease, but not completely prevent in vivo cyst 
formation of the parasites. This evidence further validates the involvement o f HSPs in the 
process of stage conversion (Bohne et al., 1998).
1.1.4 T. gondii culture conditions and parasite strains
Toxoplasma gondii can be in vitro cultured in different cell types. Human foreskin 
fibroblasts (HFF) are the most widely used because they quickly propagate and survive in 
the presence of many growth-inhibiting drugs, such as those used during the selection of 
transgenic parasites. Additionally, they allow the parasites to replicate for several cycles 
before lysis (Freyre, 1995; Roos et al., 1994). Various cell cultures, namely Vero cells,
9
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Hela cells and T cells, are commonly used in the culture of T. gondii (Cleary et al., 2002; 
Boothroyd et al., 1997).
There are several experimental strains o f T. gondii. Each strain exhibits different 
replication rates, virulence and ability to form in vitro cysts and are thus suitable for 
different experimental design (Freyre, 1995). An experimental strain called RH is highly 
virulent and fast-duplicating and the most commonly used in biochemical experiments, 
particularly in the characterization of parasite virulence and production drug-resistant 
mutant lines (Roos et a l, 1994). However, the RH strain exhibits less ability to form 
tissue-cysts, thus produces few tissue cysts in mouse when cultured in vitro. Moreover 
the RH strain can not undergo the sexual replication in the definite hosts (Freyre, 1995). 
Other strains, such as ME49 produce more tissue cysts and are thus ideal for study on 
bradyzoite development and differentiation. A subclone o f ME49 strain, referred to as the 
PLK strain, shows slower replicating rates and is widely used for the study o f life cycle 
and stage conversion of T. gondii, due to its ability to undergo complete sexual life cycle 
and to convert between tachyzoites and brayzoites (Soete et al., 1993; Boothroyd et al.,
1997).
1.1.5 T. gondii as an experimental model for apicomplexan parasites
Many members o f Apicomplexa are pathogenic. For example, Plasmodium 
falciparum is the causing agent o f malaria. It is difficult to culture and maintain in the 
laboratory, thus impeding the experimental studies (Sibley, 2003). T. gondii, on the other
10
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
hand, can be easily maintained in vitro using standard cell culture techniques. In addition, 
this parasite is amenable for molecular transformation and is thus ideal for genetic 
manipulation and analysis. Genetic manipulation by molecular transformation, including 
both transient transformation and stable transformation, has been widely employed as a 
tool to verify gene function and molecular events at various stages o f T. gondii (Kim and 
Weiss, 2004). The modulations o f T. gondii gene expressions by molecular tools such as 
insertional mutagenesis, tetracycline-repressor-based inducible systems, are extensively 
utilized to analyze gene functions (Donald and Roos, 1995; Nakaar et al., 2000; Meissner 
et al., 2001). T. gondii has an 80 Mb haploid genome consisting o f 14 chromosomes 
during its asexual life cycle, which facilitates the generation o f loss-of-function mutants 
(Black and Boothroyd, 1998; Khan et al., 2005). Additionally, most o f the genome 
sequence of T. gondii has been revealed (ToxoDB, http://www.toxodb.org, (Kissinger et 
al., 2003). Several genes of T. gondii are representive of related genes found in other 
related Apicomplexans. Thus this parasite is widely used as an experimental model (Roos 
et al., 1994; Black and Boothroyd, 2000; Kim and Weiss, 2004).
1.1.6 Genetic manipulation of T. gondii
1.1.6.1 Transient and stable transformation
The development of molecular transformation of T. gondii has made genetic 
manipulation a highly employed tool to study gene functions and molecular events o f the 
parasites. Electroporation, introducing exogenous DNA or RNA into cells by the pulse of
ii
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current, is the most efficient technique to introduce nucleic acids into T. gondii. In 
transient transformation, several reporter genes such as P-galactosidase (LacZ) and 
chloramphenicol acetyltransferase (CAT) have been successfully employed. Their 
expressions are efficient when driven by T. gondii promoters such as those of the major 
surface antigen (Lekutis et al., 2000), the rhoptry protein (Soldati et al., 1995) and the 
P-tubulin (TUB1) (Roos et al., 1994; Soldati et al., 1995)
Stable transformation, resulting in the generation o f parasite lines that permanently 
express transgenes by directed (homologous) or random integration (non-homologues 
recombinants) into the parasite genome, has widely been used (Donald and Roos, 1994). 
Moreover, Black and Boothroyd (1998) developed an episomal vector, which is able to 
replicate autonomously in T. gondii without integrating into the genome. They found that, 
when they randomly used DNA fragments isolated from the Toxoplasma genomic DNA 
to construct into transforming plasmids, some of these sequences permit the episomal 
maintenance o f the plasmid in the parasites. These episomal vectors avoid the possibility 
of introducing mutations into the genome by non-homologous recombination. Episomal 
vectors also offer the advantage of allowing easy analysis of the activity attributed to the 
transformed DNA. This is accomplished by isolating the episome to re-transform the 
parental strain or by selecting against the episom e using a negative selectable marker. The 
development o f this molecule tool may help to understand the events critical to T. gondii 
such as invasion, intracellular replication, and differentiation (Black and Boothroyd,
1998).
12
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1.1.6.2 Selectable markers for stable transformation
Selectable markers are required for gene transformation that cannot be selected 
directly. Two non-essential enzymes involved in the nucleotide pathways o f T. gondii, 
uracil phosphoribosyl transferase (Al-Anouti et a l,  2003) and 
hypoxanthine-xanthine-guanine phosphoribosyl transferase (HXGPRT), as well as other 
enzymes like dihydrofolate reductase-thymidylate synthase (DHFR-TS) and 
chloramphenicol acetyltransferase (CAT) are utilized efficiently as the selectable markers 
for T. gondii transformation (Donald and Roos, 1994).
HXGPRT is important for the purine salvage pathway o f T. gondii. It catalyzes the 
conversion from hypoxanthine, xanthine, and guanine into inosine monophosphate (IMP), 
xanthosine monophosphate (XMP) and guanine monophosphate (GMP) respectively. 
XMP can be further utilized for the synthesis o f GMP, and can also be generated from 
IMP by IMP dehydrogenase in the absence of xanthine or HXGPRT (Fig. 1.2). HXGPRT 
can also catalyze the conversion from 6-thioxanthine (6-TX) to 
6-thioxanthosine-5'-phosphate, which is toxic to the parasites. However, 6-TX cannot be 
recognized by mammalian host cells that lack the XPRT activity. Thus HXGPRT can be 
utilized as a negative selectable marker using 6-TX as the selection (Chaudhary et al., 
2004; Donald et al., 1996). The generation of HXGPRT  knockout T. gondii strains (RHA 
HXGPRT, FLKAHXGPRT) makes it possible to use HXGPRT as a positive selectable 
marker for molecular transformation. The positive selection requires the existence of
13
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mycophenic acid (MPA) and xanthine. MPA inhibits the activity o f IMP dehydrogenase 
and thus prevents the formation o f XMP and subsequent GMP, which is essential for T. 
gondii survival using this pathway. Parasites with HXGPRT expression can utilize 
HXGPRT to generate XMP from xanthine and maintain their lives, while those without 
HXGPRT expression would be killed (Donald et al., 1996). The HXGPRT knockout 
strains can be used in transformation with plasmids that express HXGPRT and the 
medium supplemented with MPA and xanthine is effective to select transformed parasites 
from those without.
14
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Figure 1.2
Purine Salvage Pathway of Toxoplasma gondii 
Legend
Schematic representation o f purine salvage pathway of T. gondii. Enzymes are indicated 
by arrows labeled AK (adenosine kinase), HXGPRT, or with numbers in the Toxoplasma 
panel (unless otherwise indicated): 1, adenosine deaminase; 2, purine nucleoside 
phosphorylase; 3, adenine deaminase; 4, AMP deaminase; 5, IMP dehydrogenase 
(inhibition target o f MPA); 6, GMP synthetase; 7, adenylosuccinate synthetase; 8, 
adenylosuccinate lyase. HC, host cell cytoplasm; PV, parasitophorous vacuole; PC, 
protist cytoplasm (Chaudhary et al., 2004).
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Figure 1.2
Purine Salvage Pathway of Toxoplasma gondii
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1.1.6.3 RNA tools in T.gondii
RNA tools, including ribozyme and antisese RNA, have been used for the 
down-regulation of gene expression in many organisms including T. gondii (Al-Anouti 
and Ananvoranich, 2002; Sheng et al., 2004; Nakaar et al., 2000; Nakaar et al., 1999). 
They are efficient for the study on essential genes functions, because these RNA tools 
have the advantage that they do not disrupt gene expression at the DNA level as the DNA 
transformation (Lamond and Sproat, 1993). Moreover, these RNA tools can be used in 
suppressing gene expression and in phenotypic studies.
Antisense RNA functions by base-pairing with target mRNA to interrupt the 
downstream process (i.e. translation) or by destroying the target mRNA by RNase H 
(Lamond and Sproat, 1993; Hostomsky et al., 1994). It was employed to modify the 
expression o f triphosphoate hydrolase (NTPase) as well as HXGPRT in T. gondii (Nakaar 
et a l,  1999). Ribozyme, first discovered by Cech and Altman in the 1980s, are RNA 
molecules that can catalyze RNA cleavage in a site-specific manner (Tanner, 1999). In T. 
gondii, engineered delta ribozymes were successfully utilized to reduce the expression of 
UPRT and HXGPRT (Sheng et al., 2004).
RNA interference (RNAi), an endogenous machinery o f gene regulation, is 
functional in many eukaryotic organisms (Hannon, 2002; Fire et ah, 1998). In T. gondii, 
when dsRNA homologous to UPRT is introduced into the parasites, the expression level 
of UPRT is lowered (Al-Anouti et al., 2003). The efficacies in gene silencing of dsRNA
17
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and delta ribozyme are similar and are much higher than that o f antisense RNA 
(Al-Anouti and Ananvoranich, 2002).
1.2 Enolase
Enolase (2 phospho-D-glycerate hydrolase, EC 4.2.1.11) is a glycolytic 
metal-activated enzyme. It belongs to the enolase superfamily comprising among other 
carboxyphosphonoenolpyruvate synthase. The enzyme catalyzes the Mg2+-dependent 
removal o f one water molecule from 2-phosphoglycerate (2PGA) to yield 
phosphoenolpyruvate (PEP), the penultimate step in the conversion of glucose to 
pyruvate. This reaction step is the only dehydration reaction in the glycolysis pathway. 
Moreover, enolase also catalyzes the reverse reaction during the process of 
gluconeogenesis. This glycolytic enzyme usually exists as a dimer o f 45-48 kDa subunits, 
in which one magnesium ion is required for each subunit (Lebioda and Stec, 1991). 
Moreover, this enzyme is found to be highly conserved among different species from 
archaebacteria to mammals.
1.2.1 Enolase isoforms in T. gondii
In T. gondii, two isoforms o f enolases are known as ENOl and EN02. Genes 
encoding these two enolase isoforms, showing 65.8% in open reading frame (ORF) 
nucleotide sequence identity, are localized on Chromosome VIII o f T. gondii, residing 
closely to each other. ENOl and EN 02 exhibit 73.8% amino acid similarity. ENOl is
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expressed only in bradyzoites and EN02 is specifically expressed in tachyzoites. 
Compared to enolases from other organisms, the T. gondii enolase isoforms carry a 
pentapeptide EWGY(W)S(C) (103-107 aa) insertion and a dipeptide E(D)K (263 and 264 
aa) and are thus considered highly related to those of plants (Dzierszinski et al., 1999). 
During differentiation between tachyzoites and bradyzoites, enolase is important for 
glycolysis and anaerobic respiration. It has thus been hypothesized that ENOl and EN02 
might be a promising target for developing drugs for chronic toxoplasmosis.
Comparing characterizations o f these two enolase isoforms using recombinant 
proteins, it was found that ENOl and EN02 exhibit similar kinetic parameters: Michaelis 
constant (Kirkman et al., 2001) o f 76.8pM vs. 77.7pM. However, EN02 had threefold 
higher specific activity ( Vmax -  89.2 mmol x m in'1 x m g'1) than ENOl (Fmax. = 34.1 mmol 
x min'1 x m g'1). Both isoforms have a similar optimum pH at pH 7.2. But ENOl is 
slightly more stable than EN02. The denaturation temperature o f ENOl was estimated at 
64.0 °C, while that o f EN02 at 57.0 °C (Dzierszinski et al., 2001). The different 
expression patterns as well as different enzymatic characterizations of ENOl and EN02 
suggest that these two isoforms might be related to the different metabolism rates of 
tachyzoites and bradyzoites. EN02, which is more active and less stable, is expressed 
only in the virulent tachyzoite stage, supposedly important for rapid development. ENOl, 
less active but more stable than EN02, is more suitable for the encysted dormant 
bradyzoite with less energetic requirements. ENOl and EN02 are distinct in their 
antigenic properties. The polyclonal antibodies raised against ENOl do not cross-react
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with EN 02, vice versa, despite the high degree of amino acid homology (Dzierszinski et 
al., 2001). It hypothesized that the difference in the expression pattern of enolase 
isoforms, as well as other stage-specific metabolism enzymes such as LDH and GP6I, is 
necessary for environmental adaptation and metabolic requirements o f  the two different 
parasitic stages. However, little is known about how the expressions of these stage 
specific enzymes are regulated during the stage conversion.
1.2.2 Structural features of enolase
Similar to enolases in other organisms, the two enolase isoforms of T. gondii 
contain conserved amino acid residues important for their catalytic activity. As indicated 
in Figure 1.3, these amino acids are Glul74, Glu217 and Lys355, which are involved in 
the dehydratation step; Asp252, Glu303 and Asp330, whose carboxylate groups 
coordinate the conformational metal ion ligand (Mg2+) required for substrate binding; 
Arg384 interacting with the phosphate group of 2-PGA; and His383 and Lys406 
interacting with the carboxylic group o f 2-PGA (Dzierszinski et al., 2001; Lebioda et al., 
1989; Lebioda and Stec, 1991). The different characterization of ENOl and EN02 might 
be due to the difference in the residues surrounding or neighboring those residues directly 
involved in the substrate binding or catalysis.
The deletion o f the two plant-like motifs in ENOl decreases its activity 
(Dzierszinski et al., 2001). These two plant-like peptide insertions are positioned in 
highly conserved regions. The dipeptide insertion localized on the amino acids 263 and
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264 aa is in one o f the connection loops intruding into the active site o f EN02 and ENOl. 
The pentapeptide insertion found at position 103-107 aa increases the length of a 
connecting loop in the C-terminal domain and makes it close to the active site of the 
enzyme. These structural features provide possible explanation to the significance of 
these two insertions in the activity o f enzyme. These plant-like motifs are also found in 
enolase o f Plasmodium falciparum, another member of Apicomplexa family (Read et al.,
1994). This feature may suggest that Apicomplexa and plants are derived from a common 
ancestor, or Apicomplexa acquired their enolase by an endosymbiotic gene transfer from 
the cyanobacterial ancestors of the green algal plastid in their cytosol.
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Figure 1.3
Sequence Alignment of ENOl and E N 02  
Legend
The amino acid sequnce of T. gondii ENOl and EN02 is aligned using LALIGN 
program (http://www.ch.embnet.org/software/LALIGN form.htmQ. Two plant-like 
motifs (103-107 aa EW GY(W )S(C), 263 and 264 aa E(D)K) are shown in green colour. 
And conserved amino acids (Glul74, Glu217, Asp252, Glu303, Asp330, Lys355, His383, 
Arg384 and Lys406) important for catalytic activity are shown in red colour
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Figure 1.3 Sequence alignment of ENOl and E N 02
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1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  1 8 0
E N O l  I A C C R A G A A S K G L P L Y K Y I A T L A G K T I D K M V M P V P F F N V I N G G E H A G N G L A L Q E F L I A P V
E N 0 2  M A C C R A G A A A K G M P L Y K Y I A T L A G N P T D K M V M P V P F F N V I N G G S H A G N K V A M Q F .F M I A P V  
1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  1 8 0
1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
E N O l  G A P N I R E A I R Y G S E T Y H H L K N V I K N K Y G L D A T N V G D E G G F A P N V A T A E E A L N L L V E A I K A
E N 0 2  G A S T I Q E A I Q I G A E V Y Q H L K W I K K K Y G L D A T N V G D E G G F A P N I S G A T E A L D L L M E A I K V  
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ENOl SVTEAIEACLLAQKSGWGVQVSHRSGETEDSFIADLWGLRCGQIKSGSPCRSERLCKYN
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E N O l  Q L M R I E E S L G A D C V Y A G E S F R H P K
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4 3 0  4 4 0
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1.2.3 Multiple functions of enolase
As a glycolytic enzyme, enolases localize in the cytoplasm, where they can be free 
or easy to associate with the cytoskeleton and other glycolytic enzymes. In T. gondii, 
ENOl and EN02 are localized in the cytoplasm and nuclei, although there is no classic 
nuclear localization signal found in their amino acid sequences (Ferguson et a l,  2002). 
This discovery suggests that, T. gondii enolase might have some additional functions, 
such as nuclear activities (i.e. division) and regulation of gene expression.
In other organisms, enolase has also been reported to perform multiple functions. 
For example, a-enolase, one of the three isoforms of enolase found in animals, is 
identified as the eye lens crystallin in reptiles and birds (Piatigorsky and Wistow, 1989). 
In HeLa cells, a-enolase acts as a component o f the centrosome, and one of its alternative 
transcript products known as rayopromoter binding protein 1 (Feo et a l, 2000) can bind 
to c-myc promoter and negatively regulate transcription o f this protooncogene (Johnstone 
et al., 1992; Ghosh et al., 1999). In human peripheral blood cells, a-enolase functions as a 
plasminogen receptor (Redlitz et a l, 1995), and is one of the hypoxia-inducible proteins 
(Semenza et a l, 1996). In fusion yeast Saccharomyces cerevisiae, enolase is the heat 
shock protein HSP48 and involved in thermal tolerance and growth control in this 
organism. Thus yeast enolase is recruited as a cofactor of tRNA targeting toward 
mitochondria (Iida and Yahara, 1985).
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Apart from their metabolitic functions, it is not yet known whether T. gondii 
enolase isoforms have additional functions. One of the focuses o f this study is to reveal 
the physiological functions of ENOl and EN 02 in the development o f T. gondii.
1.3 Gene silencing in T. gondii
In order to study the roles of EN02 in T. gondii, I chose to suppress or silence the 
expression of EN02 in the parasites. Upon the silencing o f EN 02, resultant 
loss-of-function phenotypes may provide useful information on the functions of this 
enzyme. In this section, I will review some techniques used in loss-of-functions 
phenotype analysis in T. gondii.
1.3.1 Gene targeting in T. gondii
Gene targeting, including gene knockout and knockin, has been widely used in 
many organisms such as yeast, Arabidopsis, Drosophila and mouse for analysis o f gene 
functions. Gene targeting is based on homologous recombination, which involves the 
exchange o f DNA between sequences of perfect or near perfect homology over several 
hundreds o f base pairs. The process o f homologous recombination plays essential roles in 
the mitotic and meiotic cell cycles o f most eukaryotic organisms. However, in most o f the 
eukaryotes, the opportunity of homologous recombination is extremely low when 
compared with non-homologous recombination, rendering the efficiency of gene 
targeting to be low as well (Muller, 1999).
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Toxoplasma gondii, which has haploid genome during its asexual life cycle, is very 
amendable for gene silencing and replacement. In gene targeting, constructs carrying the 
desired mutated allele of the interested gene with selectable markers are used in the 
transformation of parasites, and the homologous DNA fragment targets would guide and 
direct the homologous recombination to occur at corresponding chromosome locus. Thus, 
researchers can disrupt or delete the target gene or part of it (so-called knockout, KO), or 
replace the original gene with either a mutated one or another gene (so-called knockin, KI) 
(Koller and Smithies, 1992; Hanin and Paszkowski, 2003; Rong, 2002). Up to now, 
several genes o f T. gondii, including HXGPRT, UPRT, dihydrofolate 
reductase-thymidylate synthase (DHFR-TS) and BAG1 were reported to be knocked-out 
or replaced (Donald and Roos, 1998; Bohne et al., 1998; Bohne et al., 1994; Donald and 
Roos, 1994).
One of the often-utilized methods to increase the efficiency of gene targeting is 
increasing the length of homologous regions required for homologous recombination. At 
the locus of T. gondii DHFR-TS, when genomic fragments of 8 kb homology were used 
as a circular plasmid in the transformation, ~50% of the transformed parasites harbored 
transgenes integrated by homologous transformation. When a 16 kb genomic fragment 
was utilized, >80% homologous recombination was observed (Donald and Roos, 1994).
Furthermore, advancements o f positive-negative selection system and efficient 
molecular screening methods have made gene targeting more effective in many 
organisms (Mansour et al., 1988). Additionally, the development o f conditional gene
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targeting including tissue- or cell-type specific gene targeting and temporal-inducible 
gene targeting has rendered gene targeting a more flexible and promising tools for the 
study o f various genes (Sauer, 1998; Utomo et ah, 1999).
It is possible to generate null mutants by gene knockout in T. gondii, which enables 
the study of gene function that can lead to the identification o f potential drug targets. 
Although the frequency of homologous recombination in T. gondii is relatively high, it is 
not convenient to silence enolase isoforms by gene targeting becausetheir genomic loci 
are almost overlapped. To create a knockout or a knockin of either ENO l or EN 02  would 
interfere with the other. Moreover, it is highly likely that the null mutant would be lethal. 
To circumvent these potential difficulties, RNA interference is used. The introduction of 
dsRNA would attenuate the expression of enolases and allow us to dissect their functions.
1.3.2 RNA interference
RNAi is one o f the most remarkable biological discoveries in the last 20 years. It is 
an evolutionary conserved mechanism in which double-stranded RNA (dsRNA) or small 
interference RNA (siRNA) initiates the specific silencing of homologous genes. It is a 
mechanism that is widely found in eukaryotes, including protozoa, insects and mammals 
(Fire et al., 1998). It may function as a defensive mechanism to block the expression of 
aberrant or harmful genes originating from viruses and transposons (Hannon, 2002). 
RNAi also plays a fundamental role in genome rearrangement, chromosome remodeling 
and stem cell maintenance (Sugiyama et al., 2005; Hatfield et al., 2005; Mochizuki and
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Gorovsky, 2005). Most importantly, RNAi is one o f the most powerful and convenient 
tools to knock down specific gene expression and has a potential for gene therapy 
(Novina and Sharp, 2004; Harper et al., 2005).
1.3.2.1 The discovery of RNA interference
The first observed phenomenon o f RNAi took place in 1990 in plant research when 
scientists introduced a transgene designed to overexpress the enzyme chalcone synthase 
in petunias aimed to deepen floral color. Unexpectedly these researchers found white 
patchy flowers instead o f the expected increased flower pigmentation (Napoli et al., 1990; 
van der Krol et al., 1990). They thought that it was the transgene that silenced the 
expression o f the plant purple-flower genes. The phenomenon was named as 
co-suppression, because the exogenous transgene suppressed the expression o f itself as 
well as its endogenous homolog. The phenomenon remained obscure until similar gene 
silencing effects (known as quelling) was observed in Caenorhabditis elegans upon 
injection o f dsRNA (Fire et al., 1998). It was found that it was the dsRNA that lead to the 
degradation o f target mRNA, known as post-transcriptional gene silencing (PTGS). Later 
it was reported that RNAi was also functional in other organisms including fusion yeast 
Schizosaccharomyces pombe, Drosophila melanogaste, Arabidopsis thaliana, 
Neurospora crassa as well as mammals (Hannon, 2002). Furthermore, it was also 
reported that RNAi activity can persist through cell division rounds and growth, and that 
RNAi is inheritable and transmissible (Fire et al., 1998).
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1.3.2.2 The mechanism of RNA interference
It is suggested that the suppressive effects of RNAi can operate on several different 
levels. The co-suppression effects in plants is triggered by DNA methylation of the genes 
which are homologous to dsRNA at cytosine residues, and thus these modified genes are 
prevented from being transcribed (Wassenegger, 2005). However, the cleavage o f mRNA 
homologous to dsRNA in post-transcriptional level is usually thought to be the most 
essential pathway for the silencing effects o f dsRNA.
Genetic and biochemical studies have contributed tremendously to the 
understanding of the mechanism of RNAi. Using extracts from Drosophila embryos and 
tissue-cultured cells transfected with dsRNA, a nuclease capable of degrading exogenous 
homologous mRNA, was partially purified. This nuclease was co-purified with small 
RNAs of 21-25 nt long consisting of sense and antisense sequences derived from within 
the used regions (Tuschl et al., 1999; Elbashir et al., 2001; Yang et al., 2000). Incubation 
o f a cell-free system from Drosophila embryos with both the dsRNA and its homologous 
mRNA exhibited RNAi activity as found in vivo. And preincubation o f the cell-free lysate 
with the dsRNA potentiated the degrading activity of the lysate on the target mRNA in 
vitro (Hammond et al., 2000; Zamore et al., 2000). These series of experiments led to a 
model o f RNAi pathways consisting of initiation and effecter steps.
In the initiation step, an RNase III like enzyme known as Dicer recognizes and 
digests dsRNA into small interference RNA (siRNA) in an ATP-dependent manner. Dicer,
30
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
a highly conserved protein found in worms, flies, plants, fungi and mammals, basically 
consists of a dsRNA binding domain and one or two RNase III nuclease domains 
(Elbashir et al., 2001). These 21-25 nt siRNA, RNA duplex carrying 5’-phosphate and 
3 ’-hydroxyl termini with 2-nt overhanging 3 ' end, can later incorporates into a -360 kDa 
ribonucleoprotein nuclease-complex called the RNA induced silencing complex (RISC) 
(Hannon, 2002). The exact components of RISC are not clear now, with the exception of 
the Argonaute family protein that is supposed to be the essential element in the complex. 
The Argonaute proteins are divided into two sub-families, known as Argonaute 1-like 
(after the Arabidopsis Argonaute 1) and Piwi-like (after the Drosophila Piwi), depending 
on the existence of N-terminal PAZ domain in addition to the highly conserved 
C-terminal Piwi domain found in all Argonaute proteins (Liu et al., 2004). Argonaute 
proteins were reported to be able to bind with Dicer, suggesting that their interaction is 
important for the loading of siRNA into RISC. In the effecter step, the siRNA is first 
unwound in an ATP-dependent process. The formed single-stranded small RNA guides 
the RISC to homologous mRNA and subsequently cleaves it at 10-11 nt away from the 3 ’ 
terminus of the guide RNA. The 5 'phosphate group on the siRNA is essential for 
assembly with the RISC and subsequent target cleavage (Elbashir et al., 2001; Hannon, 
2002). Moreover, heterochromatin formation is also one possible pathway to inhibit 
target gene expression (Wassenegger, 2005).
Furthermore, Dicer can digest hairpin RNA precursors into micro RNA (miRNA), 
20-25 nt single-stranded RNA that is able to mediate translation repression. miRNA can
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incorporate into a protein complex known as miRNA-containing ribonucloprotein 
(miRNP) complex, which also contains a Argonaute family protein. In some organisms 
such as human, miRNP can guide miRNA to bind with homologous mRNA and inhibit its 
translation without affecting mRNA levels (Nelson et al., 2004).
Other components o f RNAi machinery, including R2D2, a Dicer interacting protein 
found to be important to load siRNA into RISC, were also reported. Among them, RNA 
dependent RNA polymerase (RdRP), which was reported to be able to amplify RNAi 
signals, is suggested to be essential for RNAi in some organisms, such as Neurospora 
crassa, and Schizosaccharomyces pombe (Cogoni and Macino, 1999; Hall et al., 2002). 
The siRNA can bind with the target transcript as primer, and RdRP can extend the 
primers and generate the complementary RNA strand, resulting in a dsRNA which may 
serve as a new substrate for Dicer (Martienssen, 2003). Moreover, in S. pombe, it was 
also shown that RdRP was essential for RNAi-mediated heterochromatin assembly 
(Sugiyama et al., 2005; Hall et al., 2002). However, RdRP may be not required for RNAi 
in some other organisms. In Caenorhabditis elegans, it was reported that the mutant for 
the gene ego-1 encoding its RdRP homologue showed similar RNAi activity when 
compared to the wild type (Sijen et al., 2001). Drosophila and mammals, containing no 
RdRP homologues in its genome, still exhibit gene-silencing efficiency at the 
post-transcriptional level (Cottrell and Doering, 2003). It appears that RdRP is not a 
universal component o f the RNAi pathway and that its function can be organism specific.
32
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
However, it is also possible that these organisms have distinct or divergent RdRP 
expression.
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Figure 1.4 
The mechanism of RNA interference 
Legend
The first commintting step o f the RNA interference pathway is catalyzed by Dicer 
which digests endogenous and exogenous dsRNA and generates siRNAs. The siRNA is 
loaded into RISC and directs the complex to silence gene by mRNA degradation, 
translational inhibition, or chromatin remodeling. In some organisms, RdRP-dependent 
synthesis of new dsRNA may be used to amplify RNAi signals. The figure is adopted 
from Hannon GJ, 2002
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Figure 1.4 
The mechanism of RNA interference
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1.3.2.3 The application of RNA interference
RNAi is a powerful tool to suppress specific gene expression for reverse genetic 
studies and to elucidate the functions o f genes in different organisms. The emergence of 
high throughput RNAi microarray chips has provided an important tool to analyze the 
functions o f new genes coming from high throughput sequencing centers (Silva et al., 
2004). Moreover, RNAi technology is frequently employed in identify novel drug targets 
and is a potential therapy for some diseases. Many pharmaceutical companies and 
research centers have launched RNAi-therapy programs. Actually, any diseases could be 
potential targets for RNAi-therapy. For example, in mice, siRNA homologous tumor 
necrosis factor a  (TNFa) was reported to be able to inhibit joint inflammation caused by 
collagen induced arthritis (CIA) (Schiffelers et al., 2005). In addition, by using siRNA 
expression vector to inhibit the expression o f HIV cellular receptor CD4 and coreceptors 
CXCR4 and CCR5, HIV infection on T cells can be significantly reduced (Anderson and 
Akkina, 2005). Specific siRNA is also reported to be able to inhibit growth of cancer 
cells (Takei et al., 2004; Leng and Mixson, 2005).
For the application of RNAi in research, many parameters need to be considered 
including specificities and length of the dsRNA utilized, types o f cells employed, as well 
as the method o f dsRNA delivery. In tissue culture, methods such as electroporation, 
microinjection, and lipid mediated gene delivery are often used to deliver dsRNA or 
siRNA to cells (Parrish and Fire, 2001; Elbashir et al., 2001). For Caenorhabditis elegans, 
feeding on dsRNA-expressing bacteria or even soaking in the solution of dsRNA can
36
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
successfully deliver dsRNA into cells (Timmons and Fire, 1998; Tabara et al., 1998). 
Moreover, stable transformations, which can produce stable RNAi effects, with vectors 
expressing dsRNA and siRNA, have been put into practice. The target sequence can be 
inserted into a plasmid as inverted repeats so that the dsRNA is expressed as a hairpin 
dsRNA in vivo (Sui et al., 2002; Paddison et al., 2002). A target sequence can also be 
placed between two promoters arranged in a head-to-head fashion (Tschudi et al., 2003; 
Al-Anouti et al., 2004; LaCount et al., 2000). In addition, inducible expression systems 
such as tetracycline-inducible vectors, and stage- and tissue-specific expression systems, 
were reported to be utilized in RNA silencing experiment and may have great prospect in 
the future study (Cottrell and Doering, 2003; Anderson and Akkina, 2005).
However, there is some concerns about using dsRNA in mammalian systems due to 
a protective antiviral response system which leads to a non-specific inhibition of host 
gene expression (Huppi et al., 2005). But this difficulty can be avoided by using 
embryonic cells instead of non-embryonic cells, or by using siRNA instead of long 
dsRNA (Yang et al., 2002; Elbashir et al., 2001; Huppi et al., 2005).
1.3.2.4 RNAi in protozoa parasites
When RNAi was first put into practice for the down-regulation of gene expression, 
it was used in the protozoa Trypanosome brucei (Ngo et al., 1998). Genome searching 
has shown that T. brucei contains members o f Argonaute family proteins but no Dicer 
homologues (Shi et al., 2004; Ullu et al., 2004). For other members of the
37
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Trypanosomatidae family, Trypanosoma congonlese was found to have RNAi functions, 
while T. cruzi and Leishmania major, were revealed to be RNAi negative and their 
genome databases show no homologues of Dicer and Argonaute (Ullu et al., 2004). In 
addition, RNAi was reported to be functional in T. gondii, as well as in Plasmodium 
falciparum, another member of Apicomplexa family (Malhotra et al., 2002; McRobert 
and McConkey, 2002; Al-Anouti et al., 2003). The presence of classical RNAi genes, 
including potential homologues of Argonaute, Dicer and RdRP, were reported from 
database mining of the T. gondii predicted coding regions. The presence o f Argonaute 
family protein was reported in T. gondii, further supporting the functioning o f RNAi in 
the parasites (Riyahi et al.,).
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Objectives
Stage-specific expression and nuclear localization of enolase isoforms in 
Toxoplasma gondii suggest additional important functions o f this glycolotic enzyme in 
the parasites and provide potential drug targets for toxoplasmosis treatment. But limited 
knowledge has been acquired about enolase up to now. The objective o f this study was to 
investigate the possible role of EN02 in the development of T. gondii, including their 
involvement in parasite growth and stage differentiation. We would also like to 
investigate the effectiveness and specificity of dsRNA induced gene silencing in T. 
gondii.
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CHAPTER 2 
MATERIALS AND METHODS
2.1 Parasite Strains
Toxoplasma gondii strains RHAHX and RH were obtained from the AIDS 
Research and Reference Reagent Program, NIH. RHAHX strain is generated from RH 
strain and contains a deleted HXGPRT gene which allows for the slection of transfected 
parasites (Donald and Roos, 1998).
2.2 Materials and Chemicals
Chemicals and reagents that were used in this study are listed below.
Amersham-Pharmacia Biotech (Baie d’Urfe, Quebec).
Calf intestinal alkaline phosphatase (CIAP), T7 RNA polymerase,
2’-deoxyribonucleoside 5’-triphosphates (dNTPs), ribonucleoside triphosphates (rNTPs), 
nitrocellulose membranes, and ECL western blot detection reagent.
Baxter Diagnostics Corp. (Toronto, ON)
Nalgene ™ disposable 25mm syringe filters (0.2pm pore size) and glass Pasteur pipettes 
Bio-Rad Laboratories (Mississauga, ON)
Bromophenol Blue, Coomassie Brilliant Blue R-250, Xylene Cyanol, and Bio-Rad 
protein assay dye reagents
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Gelman Sciences (Ann Arbor, MI)
The Vacucap ™ disposable bottle-top filter for sterilization of cell media 
GibcoBRL (Burlington, ON)
Cell culture media Dulbecco’s modified medium (DMEM), minimal essential medium 
(MEM), dialyzed fetal bovine serum (dFBS), Dulbecco’s phosphate buffer supplemented 
with calcium (DPBS), Trypan Blue (4%) Trypsin-EDTA (0.25% Tripsin, lmM  EDTA) 
and penicillin-streptomycin (10,000 u/ml)
Hyclone (Logan, UT)
10% cosmic calf serum
Invitrogen Corporation (Burlington, ON)
Proteinase K, Trizol, and RNase Out ribonuclease inhibitor, TOP 10 E.coli competent 
cells and BL21 (DE3) competent cells 
Molecular Probes (Eugene, OR)
Goat anti-rabbit IgG conjugated to rhodamine 
New England BioLabs Inc.
Restriction enzymes Kpnl, Nsil, Ndel and Xbal 
Omega Bio-tek (Doraville, GA)
EaZy Nucleic Acid Isolation Plasmid Midiprep Kit 
Perkin Elmer (Norwalk, CT)
[3H] uracil and [3H] hypoxanthine monohydrogen chloride 
Promega (Madison, WI)
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Agarose, DNA polymerase (Klenow) fragments, Moloney murine leukemia virus 
(M-MLV) reverse transcriptase, RQ1 RNase-free DNase, Multicore buffer, Calf intestinal 
alkaline phosphatase (CIAP), T4 DNA ligase and restriction enzymes Sad , Hindlll, 
H indi, BamHl, EcoRl, Pvull and Xhol 
Qiagen (Mississauga, ON)
The Qiaex ® II Gel Extraction Kit 
Roche Diagnostics (Laval, Qubec)
Taq DNA polymerase
Sarstedt Incorporation (Newton, NC, USA)
Conical 15 ml and 50 ml graduated polypropylene centrifuge tubes, disposable pipette 
tips, 24 and 96 well plates, Petri dishes, cell scrapers, and T75 and T25 tissue culture 
flasks
Sigma-Aldrich (Oakville, ON)
Acetic acid, ampicillin, chloroform, DNA ladders, 4 ,6 diamidino-2-phenylindole (DAPI), 
Dolichos biflorus conjugated to fluorescein isothiocyanate (Cormack et al., 1996), 
dimethylsulfoxide (DMSO), dithiothreitol (DTT), diethylpolycarbonate (DEPC), ethanol, 
ethylenediaminetetra-acetic acid disodium salt (EDTA), ethidium bromide, formamide, 
formaldehyde, glycine, glycerol, hydrochloric acid, methanol, 
morpholinopropanesulfonic acid (MOPS), mycophenolic acid (MPA), pepsin, 
polyoxyethylene sorbitan monolaurate (Tween-20), 2-propanol, phenylmethyl sulfonyl 
fluoride (PMSF), pyruvate, scintillation fluid, sodium citrate, sodium chloride, sodium
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acetate, N,N,N’,N’ tetramethyl ethylenediamine (TEMED),
tris-hydroymethylaminomethane (Tris), Triton X-100, Trichloroacetic acid, xanthine 
TaKaRa Bio Inc.
Mung Bean Nuclease, T4 DNA ligase, restriction enzymes S ad i, H ind i, and BamHl 
USB (Cleveland, OH)
Acrylamide, bis-acrylamide, ammonium persulfate (APS), equilibrated phenol, RNase A 
and sodium dodecyl sulphate (SDS)
Wisent (Montreal)
Dialyzed fetal bovine serum (FBS)
2.3 Apparatus and instrumentation
Agarose gel electrophoresis of DNA and RNA was carried out using the Miniature 
Horizontal Gel System MLB-06 from Tyler Research Instruments. Alphalmager™ 2200 
Light Imaging System with AlphaEase software was used to view gels and take images. 
Sodium dodecyl sulfute Polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
using the vertical gel electrophoresis system, including all the glasses, Teflon combs and 
spacers, from Bethesa Research Laboratories (BRL).
Centrifugations were carried out in J2-HS Centrifuge (Beckman), the desktop 
Eppendorf Model 5415C microcentrifuge from Desaga (Sarstedt Gruppe, Germany), or 
the Br4i centrifuge (Jouan, SA). DNA, RNA and protein concentrations were quantified
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using Shimadzu UV-Visible Recording Spectrophotometer UV-160 (Agilent
Technologies, ON). The quartz cuvettes used were from Sigma.
PCR reactions were performed using the 20-well Techgene Thermal Cycler 
(Techne, Cambridge, UK). Ligation reactions and reverse transcription (RT) reactions 
were incubated in the 48-well Perkin Elmer Cetus DNA thermal Cycler (Perkin Elmer, 
Norwalk, CT).
Parasite and cell culturing was performed under the Class II type A/B3 Biosafety 
cabinet (Jouan, SA). All cultures were maintained in Thermo Forma CO2 incubator 
(Thermo Forma). Electroporations were conducted using the BTX model 600 Electro 
Cell Manipulator (Genetronics). Bacterial cultures were grown in the New Brunswick 
Scientific G-25R shaking incubator
2.4 Cell cultures
Cell and parasite culture was always conducted under sterile conditions in the Class 
II type A/B3 Biosafety cabinet (Jouan, SA), and all cultures were maintained in a CO2 
incubator (Thermo Forma).
2.4.1 Human foreskin fibroblasts (HFF) culture
Normal Human foreskin fibroblasts (HFF, obtained from Dr. D. Roos, University 
of Pennsylvania) were used as the host for T. gondii. HFF cell monolayers were cultured 
in DIO complete medium (composed of Dulbecco’s Modified Eagle Medium (DMEM)
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supplemented with 10% cosmic calf serum, 5 ptg/jul streptomycin, 5 units/ml penicillin) 
and grown in 5% CO2 atmosphere at 37 °C.
Confluent HFF cell monolayers were subcultured using trypsin solution (0.25% 
trypsin, 0.03% EDTA) followed by 1 minute incubation at 37 °C. Un-adhered cells were 
resuspended in fresh DIO complete media and split into 4-5x area o f the old culture.
HHF were stored using a solution containing 12.5% dimethyl sulfoxideand 10% 
dialyzed fetal bovine serum (FBS) in D10 medium. The cells were then aliqouted into 
cryogenic vials and stored at -80  °C and later in liquid nitrogen for future use.
2.4.2 T. gondii culture
Toxoplasma gondii was propagated in HFF grown in EDI complete medium 
(Modified Eagle Medium (MEM) containing 1% dialyzed FBS, 5 pg/pl streptomycin and 
5 units/ml penicillin) at 37 °C in 5% CO2 atmosphere. When the parasites completely 
lysed the monolayers, the plate was scraped and newly released T. gondii was used to 
infect another confluent HFF monolayer.
To store the parasites for future use, the parasites were re-suspended in solution 
containing 12.5% DMSO and 10% dialyzed FBS in EDI medium. The cells were then 
placed in freezing vials and stored at -80  °C and later in liquid nitrogen for future use.
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2.5 Construction of dsRNA expression plasmid
The DNA fragments encoding 1-542 bp nucleotides starting from start codon of 
ENOl and EN02  open reading frames (ORFs) were amplified from pENOl and pEN02 
expression plasmids acquired form Dr. S. Tomovo (Universite des Sciences et 
Technologies de Lille, France) (Dzierszinski et a l, 2001), and oligonucleotide primers 
called 5’-ENOx and 3 ’-ENOx. This set o f primers match perfectly with the ENOl gene 
sequence. They also show high homology with the EN 02  gene sequence and are found to 
be able to amplify 1-542 bp EN 02  ORF DNA fragment by PCR.
The plasmid producing dsRNA was designed to put the target sequence between 
two promoters arranged as an inverted repeat that allowed transcription o f both strands of 
the DNA sequence located between them. Such construction was reported to be 
functional in many organisms such as Trypanosoma congolense, Trypanosoma brucei as 
well as T. gondii (Bannai H et al., 2003, LaCount et al., 2000, Al-Anouti et al., 2003). 
542 bp DNA fragments of ENOl and EN 02  were placed into the plasmid vector 
p(TUB8 )2, between two TUB 8  promoters respectively. And to allow selection for the 
positively transformed parasites with medium containing mycophenolic acid (MPA) and 
xanthine, an expression cassette of hypoxanthine-xanthine-guanine 
phosphoribosyltransferase (HXGPRT) was also cloned into the constructed plasmids, 
producing plasmids named as p(TUBS)2EN01 -HX, and p(TUB8)2EN02-HX  respectively. 
An ampicillin resistant gene also existed in the plasmids for bacterial selection under 
antibiotic pressure. To serve as a negative control, a 533 bp DNA fragments of green
46
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
fluorescence protein (Cormack et al., 1996) gene amplified from plasmid 
pTub8 mycHisGF.P-.ffif by PCR using T7-5GFPmut2 and T7-3GFPmut2 primers was 
also cloned into the vector to generate the plasmid p(TUB8 ) 2  GFP-HX. The Scheme of the 
plasmids constructed is shown in Fig. 3.2. Appendix III.
The coding sequences of ENOl and EN 02  and rhoptry protein 1 (Soldati et al.,
1995) as well as Argonaut (AGO) were obtained from the T. gondii sequence database 
(http://www.toxodb.org) (Kissinger et al., 2003) and were used to design oligonucleotide 
primers (T7on5’FO P T7on3’FO P 5’ENOx, VENOx, TlonS'ENOx  and TlonVENO x, all 
sequences are listed in Appendix II) for PCR reaction.
2.5.1 RNA extraction from T. gondii
Freshly released T. gondii were passed through a 27G1/2 syringe needle, filtered 
through a 3 pm polycarbonate filter to remove host cell debris and harvested by 
centrifugation at 3,000x g for 10 minutes. The parasites were lysed using TRIZOL® 
Reagent and RNA was extracted as per the manufacturer’s instruction. The obtained RNA 
samples were dissolved in 20 pi o f DEPC H2O.
To remove genomic DNA contamination, the RNA samples were treated with 4 
units RQ1 RNase-free DNase (Promega) for 30 minutes at 37 °C. The DNase was 
inactivated by heating at 75 °C for 5 minutes, followed by phenol/chloroform treatment. 
The RNA samples were recovered from the aqueous phase by precipitating using 2.2 
volumes o f 100% ethanol and 0.1 volume o f 3 M sodium acetate (pH 5.2) and were
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centrifuged at 12000x g for 15 minutes. After washing with 70% ethanol, the RNA pellet 
was dissolved in 20 pi o f DEPC H2O.
2.5.1.1 Agarose gel electrophoresis
The total RNAs extracted from T. gondii were visualized on 1% agarose gel, and 
the presence of 18s and 28s ribosomal RNA was used as the internal control. To visualize 
the DNA or RNA in the gel, ethidium bromide was added to the agarose solution to a 
final concentration o f 10 ng/ml. The gel was allowed to solidify in the electrophoresis 
tray and was placed in the electrophoresis tank filled with lx  TAE buffer. DNA/RNA 
samples were mixed with gel loading buffer (6x: 0.25% (w/v) bromophenol blue, 0.25% 
(w/v) xylene cyanol FF, and 40% (w/v) sucrose in water) and were loaded into the well 
along. The gel was run in lx  TAE buffer for 0.5 to 1 hour at -100  v. The gel was then 
visualized and photographed in Alphaimager 2200 Light Imaging System with AlphaEase 
software.
2.5.2 Reverse transcription and polymerase chain reaction (RT-PCR)
Complementary DNA (cDNA) was generated using a reverse transcription reaction 
and oligodT-primer (Appendix II). The cDNA products were used as templates for PCR.
The concentration o f RNA was determined by measuring the absorbance at 260 nm 
([RNA] = A260nmX dilution factor x (40 pg/ml)). In order to determine the purity o f DNA 
from proteins, the absorbance was also measured at 280 nm and compared to that at 260
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n m .
2.5.2.1 Reverse transcription (RT)
The reverse transcription reactions were carried out using 2 pg of total RNA after 
DNase treatment as initial templates. The RNA samples were subjected to PCR to 
confirm no DNA contamination. 5 pmoles o f oligodT primer was add to the RNA 
samples, followed by incubation at 65 °C for 5 minutes to remove secondary structures of 
RNA, and cooling on ice for 1 minute. After centrifuging briefly, the mixture was finally 
completed in a total volume of 10 pi containing 50 mM Tris-HCl (pH 8.3), 75 mM KC1, 
10 mM DTT, 3 mM MgCb, 1 mM each dNTP, 20 u (0.5 pL) RNase-out RNase inhibitor 
and 100 u (0.5 pi) Moloney murine leukemia vims (M-MLV) reverse transcriptase 
(Promega). The reactions were incubated at 42 °C for 90 minutes, followed by heating at 
70 °C for 15 minutes to inactivate the reverse transcriptase.
2.5.2.2 Polymerase chain reaction (PCR)
Polymerase chain reactions were performed using the 20-well Techgene thermal 
cycler (Techne, Cambridge, UK). All the oligonucleotide primers used in the study were 
synthesized by Integrated DNA Technologies (Coralville, IA). The sequences o f all the 
oligonucleotide primers used in the study are listed in Appendix II. 2 pi o f RT reaction 
mixture was used for the subsequent PCR amplification. The PCR was performed in a 
total volume of 25 pL containing 75 mM Tris-HCl pH 8 .8 , 50 mM KC1, 2.5 mM MgCb,
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100 pM dNTPs, 50 pmoles of each oligonucleotide primer (5’ENOx and 3 ’ENOx), and 
0.5 pL o f Taq DNA polymerase. The reaction condition for ENO land EN02  gene 
fragments amplification was 94 °C 5 min + 35 x (94 °C 30s, 42 °C 30s, 37 °C 75s) + 72 
°C 5 min. The PCR products were visualized on 1% agarose gel.
2.5.3 Preparation of vector
The DNA plasmid p(TUB8 )2-CAT was digested with Nsil and treated by Mung 
Bean Nuclease to produce blunt ends for the cloning of the DNA fragments encoding 
ENOl or EN02. The sequences and digestion analyses o f these constructs are shown in 
Appendix III.
2.5.3.1 Plasmid miniprep
An isolated bacterial colony was used to inoculate 2 ml o f LB broth supplemented 
with ampicillin (100 pg/ml). The culture was incubated at 37 °C overnight at 250 rpm. 
Following incubation, 1.5 ml o f the culture was transferred to a 1.5-ml microtube and 
was centrifuged at 12,000x g for 1 minute to collect the cells. After removing the medium 
and drying briefly, the pelleted cells were resuspended in 1 0 0  pi of a ice-cold solution 
containing 50 mM glucose, 25 mM Tris-HCl (pH 8.0), and lOmM EDTA. Then the 
suspended cells were lysed by the addition o f 200 pi o f solution containing 0.2 N NaOH, 
1% SDS prior to incubation on ice. Following a 2 to 3 minutes incubation, 150 pi of 
ice-cold 3 M NaOAc, pH 5.2 was added to precipitate chromosomal DNA and
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SDS-protein complex. After incubation on ice for 5 minutes, the mixture was centrifuged 
at 12,000x g for 5 minutes. The clear supernatant (-450 pi) was then transferred to 
another 1.5-ml tube and 450 pi of TE-buffered phenol:chloroform:isoamyl alcohol 
(25:24:1) was added. This mixture was vortexed for 30 seconds and then centrifuged at 
12,000x g for 1 minute at room temperature. The top aqueous phase was then transferred 
to a fresh tube and 900 pi of 95% ethanol was added to precipitate the plasmid. This 
mixture was then vortexed for approximately 30 seconds and left standing at room 
temperature for 2 minutes, followed by centrifugation at 12,00x g for 10 minutes at 4°C. 
The resulting DNA pellet was washed with 450 pi o f 70% ethanol and the mixture was 
centrifuged at 7,500x g for approximately 3 minutes. The final pellet was resuspended in 
30pl of lx  TE buffer containing 20 pg/ml RNase, and incubated at 37 °C for 15 to 20 
minutes to remove RNA.
2.5.3.2 Restriction enzyme digestion
Restriction enzyme digestion was used in the analysis and preparation of plasmids 
as well as DNA fragments for cloning. The reaction mixture was made by adding 1 pi 
lOx enzyme reaction buffer provided with the enzyme and 0.5 pi o f desired enzyme to an 
adequate amount of DNA solution (<1 pg), followed by adding o f ddfEO to make the 
reactionlO pi. The mixture was incubated at 37 °C for 4 to 16 hours, followed by 
visualization using agarose gel. The treated DNA can be purified by phenol: chloroform 
treatment and precipitated with ethanol.
51
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
2.5.3.3 Mung Bean Nuclease treatment
Mung Bean Nuclease reactions were carried out to create blunt ends for the ligation 
of incompatible sticky ends. The general reaction involved the use of 25pl o f DNA (<1 
pg), 3 pi o f lOx buffer (0.03 M sodium acetate (pH 5.0), 0.05 M NaCl, 1 mM ZnC^), 0.5 
pi (45 u/pl) o f Mung Bean Nuclease (TaKaRa), and 1.5 pi of H2O. After the addition of 
Mung Bean Nuclease, the samples were incubated at 37 °C for 15 minutes to let the 
enzyme work. The treated DNA sample was either purified by phenol: chloroform 
treatment followed by ethanol precipitation, or subjected to gel purification directly.
2.5.3.4 Calf Intestinal Alkaline phosphatase (CIAP) treatment
In the process o f inserting HXGPRT  cassette into constructed plasmids, CIAP was 
used to remove the phosphate group of the vectors to prevent the self-ligation in the 
ligation reaction. Briefly, the reaction was made of 20 pi o f DNA (<1 pg), 3 pi of lOx 
CIAP buffer, 0.5 pi (1 u/pl) o f CIAP (Promega), and 6.5 pi of H2O. The reaction mixture 
was incubated at 37 °C for 30 minutes, followed by adding another 0.5 pi CIAP and 
another 30 minutes 37 °C incubation. The treated DNA sample was either purified by 
phenol: chloroform treatment followed by ethanol precipitation, or subjected to gel 
purification directly.
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2.5.4 Gel purification of DNA fragm ents
To obtain purified DNA fragments for ligation, the DNA samples were resolved on 
1% agarose gel by electrophoresis, the ENOl and EN 02  DNA fragments as well as 
plasmid vector were excised and purified using QIAEXII Gel Extraction Kit as described 
by the manufacturer (Qiagen catalog No. 20021). Finally, extracted DNA sample was 
dissolved in 30 pi of ddH20 , visualized in 1% agarose gel and frozen at -20  °C for future 
use.
2.5.5 Ligation
After purification o f the DNA fragments o f ENOl and EN 02, they were ligated 
with gel-purified p(TUB8 ) 2  plasmid vector. 4 pi o f insert was mixed with 1 pi o f vector, 1 
pi 10 x Ligase Buffer (300 mM Tris-HCl (pH 7.8) 100 mM MgCl2, 100 mM DTT and 10 
mM ATP), 0.5 pi of T4 DNA Ligase (3 u/pl) (Promega), and 3.5 pi o f ddH20 . The 
reaction was incubated overnight at 16 °C. Half of this reaction mixture was then used for 
transformation into subcloning-grade competent cells.
2.5.6 Transformation of E. coli with plasmids
To maintain sterile conditions throughout bacterial culturing procedures, all broth 
solutions and glassware were autoclaved prior to use.
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2.5.6.1 Preparation of competent bacteria
XL 1-Blue MRF’ Escherichia coli (Stratagene) was grown on an LB agar plate 
containing tetracycline (100 pg/ml). A single colony was inoculated from the plate into 3 
ml LB broth with tetracycline and grown overnight in the shaker incubator at 37 °C at 
250 rpm. The second day, 1 ml of the culture was used to inoculate a 100 ml LB broth 
without antibiotics. The bacteria were shaken at 37 °C for 3 hours to let OD595nm reaches 
04-0.6. Then, the bacteria were chilled on ice for 30 minutes and then pelleted at 4000x g 
for 15 minutes at 4 °C in 50 ml Falcon tubes. 45 ml of the supernatant was discarded and 
the remaining 10 ml was used to resuspend the bacteria pellet. 30 ml cold sterile 100 mM 
CaCL solution was then added to wash the cell pellet. The suspended pellet was 
centrifuged again at 4000x g for 15 minutes. The supernatant was removed and the pellet 
was further washed with 40 ml 100 mM CaC^ solution for two times followed by 
centrifugation. The pelleted bacteria were finally resuspended in a 2ml solution 
containing 100 mM CaCL and 25% glycerol, aliquoted into 600 pi microfuge tubes and 
finally stored at -80°C for at least overnight before use (Sambrook et al, 1989).
2.5.6.2 Transformation of competent bacteria with plasmids
Half o f the ligation reaction product was added to 25 pi o f freshly thawed 
competent E. coli. After 20 minutes o f incubation on ice, the cell suspension was heat 
shocked at 42 °C for 45 seconds and further incubated on ice for another 2 minutes. After 
the addition o f 400 pi LB broth, the bacteria were incubated at 37 °C for 30 to 45 minutes
54
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
with shaking at 250 rpm. Approximately lOOpl of this culture was spread on LB agar 
plate containing 100 pg/ml ampicillin. Plates were then incubated overnight at 37 °C 
(Sambrook et al, 1989).
2.5.7 Screening for the correctly constructed plasmids
Isolated colonies o f ampicillin resistant bacteria were screened for positive cloning 
by PCR. Literally, single colonies were picked and grown in 100 pi LB broth 
supplemented with 100 pg/ml ampicillin at 37 °C overnight. 50 pi o f the culture was 
centrifuged at 12,000x g for 1 minute. The supernatant was removed and the pelleted 
cells were resuspended in 20 pi o f TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH8.0). 
The suspension was boiled for 10 minutes and spun down at 12,000x g for 1 minute. Up 
to 2.5 pi o f the supernatant was used as the template for 25 pi PCR using primers 
flanking the insert DNA fragments. PCR products were then visualized in 1% agarose 
gel.
The potentially positive clones were further isolated by miniprep and subjected to 
restriction enzyme digestion analysis to search for the correctly constructed plasmids.
2.5.8 Insertion of HXGPRT cassette into plasmid
The HXGPRT  cassette was also cloned into the plasmids to serve as a positive 
selectable marker used to select positively transformed parasites from the untransformed 
ones. Briefly, the HXGPRT cassette DNA fragment was digested from the plasmid
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pTub8 mycHisGFP-HX by restriction enzyme SaclI. The target plasmid was also 
subjected to S ad i digestion followed by CIAP treatment. The digested HXGPRT  cassette 
insert and vector were purified by QIAEX II Gel Extraction Kit and used in ligation 
reaction as described above. The ligation products were also used to transform XL 1-Blue 
MRF’ E. coli competent cells, and were subjected to screening to get the expected 
constructs. The sequences and digestion analyses of these constructs are shown in 
Appendix III.
2.6 Transient dsRNA electroporation
To study whether dsRNA induced RNAi was available to knockdown the 
expression o f enolase in T. gondii, synthesized dsRNAs homologous to two isoforms of 
enolase were transformed into the parasites by electroporation. And the consequences of 
the dsRNA electroporation were studied by RT-PCR and western blot.
2.6.1 dsRNA synthesis by in vitro transcription
DNA templates of the transcription were synthesized by PCR using ENOx primers 
set which had 17 nucleotides T7 promoters at 5’-end of both oligonucleotides 
(T7on5’ENOx and T7on3’ENOx, sequences are listed in Appendix II). And —550 bp 
ENOl and EN O l DNA fragments were used as template for the PCR reaction. The PCR 
product was purified using phenol/chloroform purification followed by ethanol 
precipitation, and dissolved in DEPC treated water. 0.2 pg of the PCR product was used
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in the in vitro transcription reaction as the template. The transcription reaction was 
carried out in a total volume of 100 pi containing 40 mM Tris-HCl (pH 8.0), 6  mM 
MgCl2 , 10 mM NaCl, 10 mM DTT, 1/100 dilution pyrophosphate, 50 u RNaseOUT 
RNAase inhibitor, 2.5 mM rNTP and 200 u T7 RNA polymerase. Transcription was 
allowed to proceed at 37°C for 2.5 hours. At the end of the incubation period, 2 units of 
RNase free RQ1 DNase were add to the reaction, following by further incubated for 30 
minutes to degrade DNA template. The product was finally purified by phenol: 
chloroform extraction and the integrity o f the RNA sample was be confirmed by 
resolving the sample on 1% agarose gel stained with ethidium bromide (Sambrook, 1989). 
The concentration of synthesized RNA was determined by spectrometry as described 
above. Additionally, dsRNA homologous to GFP DNA was also produced with the same 
approach.
2.6.2 Electroporation of dsRNA into T. gondii
After T. gondii tachyzoites o f strain RH had completely lysed a confluent HFF 
monolayers plate, the parsites were scraped from culture plate, syringed through a 
27G1/2 needle twice, filtered through a 3 pm membrane to remove host cellular debris. 
The parasites were then harvested by centrifugation at 2000x g for 10 minutes at 4 °C 
followed by washing twice with Dulbecco’s phosphate-buffered saline buffer
' y i
supplemented with 100 pg/ml Ca (DPBS). The parasites were finally centrifuged at 
2000x g for 10 minutes at 4 °C to collect the pellets, then resuspended in 800 pi
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electroporation buffer which contained 120 mM KC1, 0.15 mM CaCh, 10 mM 
K2HPO4/KH2PO4 (pH 7.6), 25 mM HEPES (pH 7.6), 2 mM EDTA and 5 mM MgCl2, and 
was freshly supplemented with 2 mM ATP and 5 mM glutathione (GST). 10 pg dsRNA 
was added to the resuspended T. gondii, and the mixture was transferred to the 4 mm 
electroporation cuvettes (Ultident, St. Laurent, Quebec) and subjected to electroporation 
using BTX model 600 Electro Cell Manipulator (Genetronics) with current o f 25 £2, 25 
pF and 1.8 kEV. The electroporated parasites were then left standing in the 
electroporation vial at room temperature for 15-30 minutes to restore their viabilities and 
were then used to infect a new confluent HFF monolayers in EDI medium in 60mm 
culture plate (Donald and Roos, 1994).
2.6.3 RT-PCR to study mRNA expression level
The total RNA of T. gondii after dsRNA electroporation was extracted as described 
above. The RNA samples were subjected to DNase treatment and subsequent PCR to 
confirm no DNA contamination. 2 pg o f the total RNA was used in the RT reaction using 
oligodT, which is complementary to the polyA tails of mRNA, as the primer. 2 pi of the 
RT product is used in the PCR as the templates. The reaction condition for ROP1 
amplification was 94 °C 5 min + 35 x (94 °C 30s, 55 °C 30s, 37 °C 45s) + 72°C 5 min. 
The reaction condition for EN 02  amplification was 94 °C 5 min + 35 x (94 °C 30s, 42 °C 
30s, 37 °C 75s) + 72 °C 5 min. The PCR products were subjected to agarose gel 
electrophoresis to visualize the results. To make the amount o f ROP1 products to be equal,
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5.0pL o f d&ENOl RNA RT-PCR product, 3.5pL o f dsE N 02  RNA RT-PCR product and 
6.0pL of dsGFP RNA RT product from both EN 02  and ROP1 were loaded on the gel.
2.6.4 Sodium dodecyl sulfate-Polyacrylamide gel electrophoresis (SDS-PAGE) 
and western blot
2.6.4.1 Protein quantification by Bradford assay
Freshly released T. gondii were passed through a 27G1/2 syringe needle, filtered 
through a 3 pm polycarbonate filter to remove host cell debris and harvested by 
centrifugation at 3,000x g for 10 minutes. The pelleted parasites were lysed with the 
protein lysis buffer containing 50 mM HEPES (pH 7.4), 0.025% Triton X-100, 20% 
glycerol, 10 mM PMSF, and centrifuged at 12,000x g for 10 minutes at 4 °C. The 
concentrations o f cell lysates were determined by Bradford assay using the Agilent 
UV-visible spectrophotometer as described on the manual. 10 pi o f the protein sample 
was diluted with 1.59ml o f ddH2 0  and mixed with 0.4 ml of Bradford reagent (Bio-Rad). 
After incubation at room temperature for 10 minutes, spectrophotometeric measurements 
were carried out at 595 nm using the diluted Bradford Reagent as a blank. A standard 
curve made with standard protein solutions of BSA was used to determine the unknown 
concentration o f protein in the sample (Sambrook et al, 1989).
2.6.4.2 SDS-PAGE
Sodium dodecyl sulfate-Polyacrylamide gel electrophoresis (SDS-PAGE) was
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conducted with a discontinuous buffer system (Laemmli, 1970). The stacking and 
resolving gels were cast using the vertical gel electrophoresis system from BRL 
(Bethesda Research Laboratories). The resolving gel solution (2.58 ml ddfLO, 1.8 ml 
30% Acrylamide solution, 1.5 ml 1.0 M Tris-HCl pH 8 .8 , 60 pi 10%SDS, 60 pi 10% 
ammonium persulfate, 5 pi TEMED to make total volume to be ~ 6 ml) was poured first 
and left to polymerize before being overlaid by the stacking gel solution (1.46 ml d d ^ O , 
0.25 ml 30% Acrylamide solution, 0.25 ml 1.0M Tris-HCl pH 6 .8 , 20 pi 10% SDS, 20 pi 
10% ammonium persulfate, 3 pi TEMED to make total volume to be ~2 ml).
The protein samples were mixed with gel loading buffer containing 6.25 mM 
Tris-HCl (pH 6 .8 ), 2% SDS, 10% glucose, 0.05% Bromophenol blue and 720 mM 
2-mercaptoethanol, boiled for 5 minutes and loaded onto SDS-PAGE gel. The gel was 
run in the Tris-glycine running buffer containing 196 mM glycine, 25 mM Tris-HCl (pH 
8.4), 0.1% SDS, at 125 volts until the bromophenol blue dye reached the end o f the gel 
(~90min).
2.6.4.3 Protein transfer and immuno-detection
The separated proteins on SDS-PAGE gel were subsequently transferred to 
nitrocellulose membrane by electro-blotting in transfer buffer containing 192 mM glycine, 
25 mM Tris-HCl (pH 7.4), 20% methanol at 80 volts for 1 to 2 hours. The efficiency of 
transfer was determined by ponceau staining.
The blot was blocked in 5% skim milk in TBS (137 mM NaCl, 20 mM Tris-HCl,
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pH 7.6) for 1 hour at room temp and then incubated in 2% skim milk containing the 
rabbit anti-EN02 antibody overnight at 4°C. After washing with TBST (0.2% Tween in 
TBS) for 3x 10 minutes, the blot was incubated in 2% skim milk containing the goat 
secondary antibody against rabbit IgG linked with horseraddish peroxidase for 1 to 2 
hours at room temperature. After another wash with TBST for 3x 10 minutes, the blot is 
visualized for EN02 signals with Detection Reagent (Amersham Bioscience, Baie d’Urfe, 
Quebec). Afterward, the blot was stripped with stripping solution containing 250 mM 
glycine-HCl (pH 2.0), 1% SDS, treated with LDH1 primary antiboady, and finally 
anti-rabbit secondary antibody to visualize LDH1 signals.
2.7 Generation of transgenic parasite lines
The constructed plasmids were used to generate transgenic parasite lines. The 
plasmids were first extracted using E.Z.N.A Plasmid Midiprep Kit (Omega Bio-tek, GA), 
and then were used to transform T. gondii strain RHAHX. The transformed parasites were 
cultured under selective pressure to produce stable transgenic parasite lines.
2.7.1 Plasmid extraction by midiprep
The constructed plasmid was extracted from E. coli using E.Z.N.A Plasmid 
Midiprep Kit from Omega Bio-tek according to manufacturer’s instruction. Literally, an 
isolated colony was used to inoculate 100 ml o f LB broth supplemented with 100 pg/ml 
ampicillin. The culture was incubated overnight at 37 °C in shaking incubator at 250 rpm.
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Then, 50 ml o f the overnight-cultured medium was placed in a 50 ml Falcon tube and the 
cells were harvested by centrifuging at 4,000x g for 10 minutes. The cells were then 
resuspended in 2.25 ml o f Solution I with RNase A. Then, the bacteria were lysed by 
adding 2.25 ml o f Solution II, followed by gentle inversion for 7 to 10 times for through 
mixing prior to incubation at room temperature for 5 minutes. The resulting mixture was 
then neutralized with 3.2 ml o f Solution III and mixed by inversion for several times until 
a flocculent white precipitate formed. The mixture was centrifuged at 12000x g for 10 
minutes at room temperature to pellet the cellular debris and genomic DNA. Then, the 
clear supernatant was transferred to a clean Hibind DNA Midi column assembled in a 
15ml collect tube. The binding column was then centrifuged at 5,000x g for 5 minutes to 
completely pass the lysate through the column (need two times to transfer all the DNA 
solution to the column). Then 3 ml o f the Binding HB buffer was added to the top o f the 
column followed by centrifugation at 5,000x g for 5 minutes. After washing the column 
with 3.5ml DNA Wash Buffer diluted with ethonal and centrifuging at 5,000x g for 5 
minutes, the resulting binding column was washed with 3 ml o f 100% ethonal and 
centrifuged at 5,000x g for 3 minutes. Then, the column is subjected to centrifugation at 
5,000x g for 10 minutes again to remove residue ethanol. Finally, 0.75 ml sterile 
deionized water was added to the column. The column was transferred to a new clean 
tube and subjected to centrifugation at 5,000x g for 5 minutes to elute out the DNA bind 
with the column. The elution process was repeated to increase the yield o f plasmid DNA. 
The DNA sample was visualized on 1% agarose gel containing ethidium bromide. The
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concentration o f the plasmid solution was determined by measuring the absorbance o f the 
DNA sample at 260 nm ([DNA] = A260nm x dilution factor x (50 pg/ml)). In order to 
determine the purity of DNA from proteins, the absorbance was also measured at 280 nm 
and compared to that at 260nm.
2.7.2 T. gondii transform ation using electroporation and selection
To produce the stable ENOl and EN02 knowckdown strains, lOpg o f the 
plasmid p(TUB 8)2.E7VC>/-HX, p(TUB8 )2EN 02-H X  as well as the control plasmid 
p(TUB8 )2GFP-//Awere used to transform the parasites strain RHAffifby electroporation 
respectively. The operation of electropration was performed as described above. After 
electroporation, the parasites were used to infect confluent HFF monolayers and 
incubated in EDI complete medium for 24h at 37 °C in 5% CO2 atmosphere. Then 
selection was applied by culturing the parasites in EDI medium complemented with 25 
pg/ml MPA and 50 pg/ml xanthine. Untransformed parasites were killed and the 
transformed ones survived due to the expression of exogenous HXGPRT. The selection 
pressure was kept to maintain the expression o f the transgenes.
2.8 Characterization of transgenic parasite lines
To characterize the generated parasite lines, their genomic DNAs were extracted 
and used as the template for PCR to check the existence o f the transgenes. Then, the 
production o f dsRNA in these parasite lines was studied using RT-PCR. The expression
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level o f enolase was also monitored in the level o f RNA and protein, by RT-PCR and 
western blot respectively.
2.8.1 Genomic DNA extraction and PCR
When T. gondii tachyzoites had completely lysed a confluent HFF monolayers, 
they were scraped from culture plates, syringed through a 27G1/2 needle twice, filtered 
through a 3 pm membrane to remove host cell debris. The cells are sedimented by 
centrifugation at 3,000x g for 10 minutes at room temperature. The collected pellet was 
washed twice with DPBS and was used for genomic DNA or total RNA extraction. To 
extract genomic DNA of T. gondii, the parasites pellet was resuspended in 250 pi 
genomic DNA lysis buffer containinglOO mM EDTA, 10 mM Tris-HCl (pH 8.0) and 1% 
SDS and 2 mg/ml Proteinase K. The mixture was incubated at 55-60 °C for 4 to 6  hours 
to completely lyse the parasites. The suspension was then extracted three times with an 
equal volume of phenol xhloroform and twice with an equal volume o f chloroform. Then, 
the genomic DNA was obtained from the aqueous phase by precipitating with two 
volumes 95% ethanol and 1/10 volume 3M sodium acetate (pH 5.2). After 15 minutes 
centrifugation at 5000x g at 4 °C, the DNA pellet was washed by 250 pi 70% ethonal and 
dissolved in 30 pi ddHaO. The genomic DNA sample was resolved on 1% agarose gel, to 
visualize the existence o f high molecular weight DNA band.
0.2 pg genomic DNA was used as the template for PCR. The 25 pi mixture of PCR 
is prepared as described above. The reaction condition for ROP1 and GFP amplification
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was 94 °C 5 min + 35 x (94 °C 30s, 55 °C 30s, 37 °C 45s) + 72°C 5 min. The reaction 
condition for ENOl and EN 02  amplification was 94 °C 5min + 35 x (94 °C 30s, 42 °C 
30s, 37 °C 75s) + 72°C 5min. The PCR products were visualized on 1% agarose gel.
2.8.2 Detection of dsRNA expression by RT-PCR
The total RNAs of different strains o f T. gondii were extracted as described above. 
The RNA samples were subjected to DNase treatment and subsequent PCR to confirm no 
DNA contamination. 2 pg of the total RNA sample was used in the RT reaction using the 
upper primers o f ENO  primer set (5’ENOx) to produce the cDNA complementary to the 
ENO antisense RNA, and primer 5 ,GFP was utilized to produce cDNA complementary 
to GFP antisense RNA. The RT reaction was conducted as described above and 2 pi of 
the RT products was used as the template for PCR to detect the production o f dsRNA.
To study the expression level o f enolase in the levels o f mRNA and protein of the 
different parasite lines, RT-PCR and western blot were utilized and the operations are 
performed as described in section 2.6.3 and 2.6.4 for transient enolase knockdown 
experiments.
2.9 Immunofluorescence Assay
Newly released parasites were inoculated onto confluent HFF monolayers grown 
on glass slides. For different stages o f the parasites, tachyzoites were then allowed to
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grow for 2-3 days, while intracellular bradyzoites were cultured for 4 days before 
analysis. After removing culture media and washed with DPBS for 3 times, the cells were 
fixed with 3% paraformaldehyde in phosphate buffered saline (PBS) for 10 minutes and 
then permeabilized with 0.2% Triton X-100 in PBS for 15 minutes. Cells were then 
blocked with 5% bovine serum albumin (BSA) in PBS for 1 hour at room temperature 
(Yahiaoui et al., 1999). Slides were incubated for 1 hour with the primary antibody in a 
humidity chamber. After three washes with PBS for 3 x 10 minutes, cells were incubated 
for another 1 hour with seconday antibody conjugated to rhodamine or Fluorescein 
isothiocyanate (Cormack et al., 1996) in a dark humidity chamber. Afterward, the slides 
were washed with PBS for another three times. The nuclei o f the cells were stained by 
incubation in the presence of 4 ' , 6  diamidino-2-phenylindole (DAPI, Sigma) for 10 
minutes, and three washings with PBS (Yahiaoui et al., 1999). For cyst staining, the cells 
were stained with lectin from Dolichos biflorus conjugated to FITC (diluted 1:300, Sigma) 
for 1 hour. The slides were dried in the air and overlaid with fluoromount, followed by 
incubation at room temperature overnight in the dark. The cells were examined with a 
Leica DMIRB microscope. All images were taken with a cooled Q-Imaging CCD camera 
using the Improvision Openlab software.
2.10 Measurement of parasite growth
The growth ability o f different parasite lines was analyzed by their amplification 
ability. Freshly released tachyzoites were used to infect confluent HFF monolayer cells in
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EDI complete medium grown on glass slides. After growing for 24h and 48h, the slides 
were washed with DPBS three times and were fixed with 3% paraformaldehyde in PBS 
for 10 minutes. After permeabilization with with 0.2% Triton X-100 in PBS for 15 
minutes, the fixed cells and parasites were incubated in DAPI solution for ten minutes to 
stain their nuclei. After drying in the air, the slides were overlaid with fluoromount, and 
incubated at room temperature overnight in the dark. The cells were examined with a 
Leica DMIRB microscope. The numbers o f vacuoles containing different numbers of 
parasites were counted and their ratios in total vacuoles were scored, and plotted.
The growth rates o f the transgenic parasite lines as well as the parental strain were 
also measured by plaque assay. Briefly, newly released parasites o f different strains were 
counted after staining with 0.4% Trypan Blue, and 5,000 live parasites were used to 
infect confluent HFF monolayers in 35mm culture plates. After 24h incubation at 37 °C in 
5% CO2 atmosphere, the plates were sealed and incubated undisturbed for at least 6  days, 
shielded from excess vibration. When plaques of adequate size for visualization were 
formed (usually ~9 days after infection), the cells were rinsed with PBS, fixed in 
methanol, stained in crystal violet (to make 5 X stock, 25 g of crystal violet was dissolved 
in 250 ml ethanol and added to 1,000 ml 1% ammonium oxalate) and air-dried. Parasites 
plaques appeared as irregular clear areas against mottled violet background produced by 
stained confluent HFF cells. The numbers of plaques were counted under optical 
microscope.
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2.11 In vitro differentiation of I  gondii
To differentiate the parasites from tachyzoites into bradyzoites, the alkaline method 
was used. Briefly, freshly released tachyzoites were used to inoculate confluent HFF cells 
in EDI complete medium and were allowed to invade the host cells for 4 hours. The 
medium was subsequently replaced with RPMI1640 medium pH 8.2, containing 25 mM 
HEPES, 5% fetal bovine serum, 5 jug/jal streptomycin, and 5 units/ml penicillin, and 
incubated in a humid air atmosphere at 37 °C with 5% CO2 . The medium was replaced 
every one or two days to maintain the pH. And parasites were harvested immediately 
after they had been released from HFF monolayers.
After 4 -6  days of bradyzoite differentiation using the alkaline method, the cells 
were scraped and digested with 170 mM NaCl-pepsin (0.1 mg/ml) to free the bradyzoites 
from the cells. After incubation in 60 mM HC1 for 1 minute at 37 °C, the cells suspension 
was neutralized with 94 mM Na2C0 3 . Collected parasites were passed through a 27G1/2 
needle twice and filtered through a 3 pm filter (Nucleopore) to remove host cell debris. 
Filter-purified parasites were then collected by centrifugation at 3,000x g for 10 minutes 
and washed twice with DPBS. The collected bradyzoites can be lysed for protein study, 
or for DNA and RNA extraction. They can also be used to infect confluent host cells in 
EDI complete medium to transfer them into tachyzoites.
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CHAPTER 3 
RESULTS
3.1 Transient knockdown of enolase expression
To investigate the function of enolase isoforms in the development and stage 
conversion o f T. gondii, we attenuated the expression of these glycolytic enzymes using 
RNAi approach. Initially, we conducted transient down-regulation assays o f ENO l and 
EN 02  to evaluate the efficiency o f dsRNA induced silencing. In vitro synthesized dsRNA 
homologous to ENO l and EN O l was electroporated into the parasites. The mock 
electroporation was also performed using only electroporation buffer. Following the 
electroporation (3-5 days), newly released parasites were collected to monitor the 
expression of ENOl and EN 02  using RT-PCR and western blot analysis. And ROP1 
expression was used to establish the baselines for a comparison between different 
electroporated parasite sets (Fig. 3.1 A, ROP1). We detected no change in mRNA level of 
T. gondii ROP1 after electroporation with dsRNA homologous to EN O l, EN O l or GFP. 
The EN 02  dsRNA electroporated parasites showed a decreased level o f EN 02  transcripts 
~75 % (Fig. 3.1 A, EN 02) and contained un-modulated levels o f ROP1 and Argonaute 
(Fig. 3.1 A, AGO), when these RT-PCR signals were compared with those of the mock 
electroporation. These results indicate that the dsRNA induced gene silencing is effective 
to specifically lower the expression of ENO l.
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To determine whether the transient gene knockdown affected the levels of gene 
products, western blot analysis was performed using polyclonal antibodies raised against 
EN02 and LDH1. We detected that EN02 was decreased following the EN 02  dsRNA 
electroporation (Fig. 3 .IB), but was not significantly affected by electroporation with 
other dsRNAs. The signals revealed by LDH1 -antibody were used as loading controls for 
the correction of protein concentrations used in the study.
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Figure 3.1
Transient down regulation of E N 02  expression 
Legend
A. Following dsRNA electroporations, total RNAs were isolated from T. gondii 
strain RH and subjected to RT-PCR analysis using the oligonucleotide primers 
specific to E N O l, ROP1 and AGO. The RNA samples used in the RT reaction 
are also shown in the figure (right panel, not quantitative). The amount o f each 
sample was quantified using spot densitometry of AlphaEase software.
B. Western blots were incubated with polyclonal antibodies against EN02 (upper 
panel), and LDE11 (lower panel). The amount of each sample was quantified 
using spot densitometry of AlphaEase software.
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Figure 3.1
Transient down regulation of E N 02 expression
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B. Western blot
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3.2 Generation of stable ENOl and E N 02 knockdown parasite lines
The results o f transient down-regulation confirmed the effectiveness and 
specificity o f dsRNA induced silencing of enolase expression. However the introduction 
o f dsRNA into T. gondii can only produce transitory knockdown effects and is unsuitable 
for the study o f their physiological functions. Therefore we created transgenic parasite 
lines using RHAHX as parental parasites to obtain stably expression o f ENO l or EN 02  
dsRNA to induce gene silecning.
The plasmids expressing dsRNA homologous to EN O l, E N 02  or GFP was 
constructed by placing the target DNA fragment between two head-to-head promoters. 
Such construction was previously used in the dsRNA expression in Trypanosoma 
congolense, Trypanosoma brucei as well as T gondii (Bannai H et al., 2003; LaCount et 
al., 2000; Al-Anouti et al., 2003). The plasmid construction was described in “Materials 
and Methods” (Fig. 3.2).
The three constructed plasmids p(TUB8 )2£vV(9 /-//A , p(T\JBS)2EN02-HX  and 
p(TUB8 ) 2 GFP-HX  were individually introduced into T. gondii strain RHAHX using 
electroporation. Transformed parasites were then cultured using medium supplemented 
with MPA and xanthine. The selection was maintained to ensure integration of the 
transforming plasmid into parasite genome. The stable transgenic parasite lines were 
named as dsENOl, dsEN02 and dsGFP respectively, according to the transforming 
plasmids used. We also tried to generate stable transgenic parasite lines using another 
parental strain, named PLKAHX, which grow slower than RHAHX and can differentiate
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to bradyzoites more efficiently. Using such a strain, we aimed at dissecting the 
knockdown effect influenced by different genetic makeup. Unfortunately we can only 
obtain stable parasite line when p(TUB$)2EN02-HX  was used, but not with other 
constructs. This parasite line is named dsEN02P.
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Figure 3.2
Schematic representation of construction strategies
Legend
A. Plasmid used in the generation o f parasite lines with dsRNA expression. Two 
tubulin promoters (Tub8 ) are arranged head-to-head and the target gene 
sequence (ENOl, EN 02  or GFP) is placed between these two promoters.
B. DNA fragments of target genes cloned into the constructed plasmids. 
Restriction sites for Hindlll and Sacl are shown in EN O l and EN 02  
fragments
76
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Figure 3.2
Scheme of constructed plasmids used to generate parasite lines
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3.3 Characterization of the transgenic parasite lines
To confirm the presence of transgenes in the genome of the parasites, total DNAs 
of the transgenic parasite lines were extracted and subjected to PCR analysis for 
comparison to the parental parasite strains. The expression o f dsRNA in the transgenic 
parasite lines was monitored by RT-PCR.
3.3.1 Confirmation of transgene integration
To confirm that the ENOl or EN02 transgenes were integrated into the parasite 
genome, we made use of the difference between the cDNA and genomic sequences. In 
the gene encoding EN O l, there is a 493 bp intron separating the first 40 bp exon from the 
rest of the coding sequence, while EN 02  gene has a 650 bp intron. We synthesized the 
oligonucleotide primers flanking these regions (5’ENOx and 3’ENOx). Using these 
primers, we can easily distinguish the transgenic genes by their smaller size following 
PCR amplification using isolated genomic DNA as templates and agarose gel 
electrophoresis.
The results o f genomic PCR are shown in Figure 3.3. PCR using 5’ENOx and 
VENOx primers, a band of ~1 kb was amplified from all samples, representing the 
genomic locus o f EN O l gene. Additional bands of approximately 540 bp, corresponding 
to the transgenic gene o f ENOl or EN02, were shown in the PCR products from genomic 
DNA sample of dsENOl and dsEN02 strains (Fig. 3.3A lane 3, 4). Since the PCR 
products of ENOl and EN 02  transgenic DNA were similar in size, these PCR products
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were further analyzed by restriction endonuclease digestion to ensure the target genes 
were properly amplified. For example, Hindlll site is present in E N O l but not ENOl 
gene. Thus Hindlll can digest the PCR products derived from EN02, but not those from 
ENOl. Similarly, S a d  will digest ENO l, but not EN 02  (Fig. 3.2B, C). The digestion 
profile confirmed the identification o f the two -540 bp bands generated from the 
transgenic strains, indicating correct integration of transgene plasmid into the genome of 
the parasites. Moreover, the genomic DNA samples were also subjected to the PCR 
reaction using T7-5GFPmut2 and T7-3GFPmut2 primer set and the band representing the 
GFP transgenic DNA was only generated from PCR using dsGFP gDNA as the template 
(Fig. 3.3B), demonstrating the exclusive presence of GFP transgene in the dsGFP strain. 
The integration o f the transgene in the strain o f dsEN02P was also confirmed by 
genomic DNA PCR.
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Figure 3.3 
Confirmation of transgene integration 
Legend
A. Total DNA samples extracted from generated transgenic parasite lines and 
parental strains were subjected to PCR to detect presence o f ENOl and EN02  
transgenes in parasite genome.
Lane 1: PCR products of gDNA from parental strain RHAHX 
Lane 2: PCR products o f gDNA from transgenic strain dsGFP 
Lane 3: PCR products o f gDNA from transgenic strain dsENOl 
Lane 4: PCR products of gDNA from transgenic strain dsEN02 
Lane 5: DNA marker
B. Total DNAs extracted from generated transgenic parasite line dsGFP and 
parental strains RHAHX were subjected to PCR to detect integration o f GFP 
transgene in parasite genome. Constructed plasmid p(TUB8 )2 GFP-HZ was 
also used in PCR to serve as a positive control (+).
C. -540 bp PCR products from dsENOl and dsEN02 genomic DNA were 
subjected to S a d  and Hindlll digestion to confirm their identities.
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Figure 3.3 
Confirmation of transgene integration
dsGFP + RHAHX
dsENOl dsEN02
Sacl Hind\\\ Sacl Hind\\\
550 bp *
250 bp— *
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3.3.2 Expression of dsRNA in the transgenic parasites
Investigation of dsRNA expression in the parasite lines is crucial. The constructed 
plasmids used to generate these parasite lines were designed to express dsRNA 
homologous to EN O l, EN 02  and GFP. Total RNA from the transgenic and parental 
strains were extracted and used in RT-PCR analysis to detect the expression of dsRNA 
using 5’-ENOx and V-ENOx primer set as well as T7-5G/?jDmut2 and T7-3GFPmut2 
primer set.
No significant band was produced in the RT-PCR using ENOx primer sets from 
RNA samples isolated from parental strain RHAHX and the control strain dsGFP, 
indicating that antisense RNA as well as dsRNA homologous to EN O l or EN 02  genes 
was not expressed in these strains. When the total RNA samples from dsENOl and 
dsEN02 strains were used in the RT-PCR using ENOx primer sets, a band of ~540 bp 
was detected in both reactions (Fig. 3.4A, top panel). These two PCR products were also 
subjected to restriction endonuclease digestion to verify their identities. The RT-PCR 
band generated from dsENOl RNA can be digested by Sacl but not Hindlll, indicating its 
homology to ENO l gene, while the RT-PCR band obtained from dsEN02 RNA can be 
cut by Hindlll but not Sacl, showing its EN 02  homology (Fig. 3.4B). These results 
showed that dsRNA homologous to ENOl is only expressed in dsENOl strain, and 
dsRNA homologous to EN 02  is exclusively expressed in dsEN02 strain. The total RNA 
samples from these four strains were also subjected to RT-PCR reaction using GFP 
primer set, and positive results were only detected from dsGFP samples (Fig. 3.4A,
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middle panel), indicating that GFP dsRNA was only produced in this transgenic T. gondii 
strain. Moreover, the expression of dsRNA homologous to EN 02  in the transgenic strain 
dsEN02Pwas also detected using the same method.
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Figure 3.4 
Confirmation of dsRNA expression 
Legend
A. Total RNA samples extracted from generated transgenic parasite lines 
(dsENOl, dsEN02, dsGFP) and parental strains (RHAHX,) were subjected to 
RT-PCR using ENOx (upper panel) and GFP (middle panel) specific primers 
to detect dsRNA production. The RNA samples used in the RT reaction are 
also shown in the figure (right panel, not quantitative).
B. -540 bp RT-PCR products from dsENOl and dsEN02 total RNA were 
subjected to Sacl and Hindlll digestion to confirm their identities.
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Figure 3.4
Expression of dsRNA
total RNA
dsENOl dsEN02 RHAHX dsGFP
dsENOl dsEN02 RHAHX dsGFP
B
dsENOl product dsEN02 product
Hind\\\ Sacl undigested Hind\\\ Sacl undigested
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3.4 The steady state level of enolase transcripts in transgenic parasite strains
Our transforming plasmids were designed to express dsRNA that would trigger 
gene silencing o f the target genes. Following the confirmation of successful expression of 
dsRNA, we consequently evaluate whether the expressions o f the target genes are 
knocked down. RT-PCR was used to assess the expression level of these target genes. 
Total RNAs were isolated from newly released tachyzoites o f the transgenic and parental 
strains and used as templates in RT reaction in which the cDNA synthesis was initated 
using oligodT as primers. Although oligodT priming might not give high yields as gene 
specific primers do, it avoid variations among different RT reactions when the cDNA 
products were used in gene-specific PCR amplification. The results o f  the RT-PCR are 
shown in Figure 3.5A, the identities o f the bands produced form ENOx RT-PCR is 
confirmed by restriction endonuclease digestion, and the ratio of EN 02/R0P1  signals 
was also calculated for each sample. The expression level of EN 02  was not changed in 
the parental strain RHAHX, the control strain dsGFP as well as the transgenic strain 
dsENOl (EN02/ROP1 ~l.O). In the strain dsEN02, the ratio o f EN 02/R0P1  was ~0.4, 
showing that the expression of EN 02  was lowered in the level of mRNA and indicating 
that the knockdown effects induced by dsRNA was gene specific. For the generated 
strain dsEN02P, compared with the parental strain PLKAHX, similar results were also 
observed (Fig. 3.5B). The expression level o f EN 02  mRNA in dsEN02P strain was 
lowered, but its ROP1 mRNA showed comparable amount with PLKAHX.
To measure the expression level of gene products in the transgenic strains and the
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parental strain, western blot analysis was conducted utilizing polyclonal antibodies 
against enolase isoforms ENOl and EN02. Equal amounts (5 pg) of protein extracts 
from freshly lysed trachyzoites were resolved in SDS-PAGE gel and transferred to 
nitrocellulose membrane. Figure 3.5C shows the results of the western blot. The lysate 
from dsEN02 strain contained less amount of EN02 protein. And no significant 
difference o f EN02 signal was detected in the control strain dsGFP, and the transgenic 
strain dsENOl from the parental strain RHAHX (Fig. 3.5C, EN02). Then, the membrane 
was stripped and LDH1 signals were detect to confirm equal loading amount (Fig.3.5C, 
LDH1). To further investigate whether ENOl, which is expressed in bradyzoite stage, 
could compensate the loss of EN02 protein, an identical blot was prepared and incubated 
with ENOl-specific antibody. Very faint signals o f ENOl were detected, suggesting that 
this enolase isoform was not expressed to compensate attenuated EN 02 expression in 
tachyzoite stage (Fig. 3.5C). The faint bands could result from cross-interaction o f EN02 
protein and ENOl - antibody.
Throughout the course o f this study, we found that the expression level o f EN02 
of transgenic strain dsEN02 was decreasing gradually following passages and selection 
by MPA and xanthine (Fig. 3.5D). The ratio between EN02 and LDH1 was ~1.6 after we 
electroporated the constructed plasmid p(TUB8 )2EN 02-H X  into the parasites and passed 
three times in HFF monolayers. The ratio decreased to -1.3 after six passages, and 
become stable at the level o f -0 .6  after nine passages. We hypothesized that if  this 
observation was due to that a more homogenous population was formed following each
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passage. Thus after RHAHX parasites were electroporated with p(TUB8)2£M92-HZ 
plasmid and completely lysed the host cells, we used them to inoculate a 24-well plate 
covered with HFF monolayers for cloning. About ten clonal parasites were acquired, five 
o f which were used to infect new host cells and passed for three times before they were 
analyzed by immunoblot. However, western blot results showed that, there was no 
significant difference between the expression level of EN02 in those transgenic parasites 
and that o f RHAHX.
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Figure 3.5 
Gene expression in transgenic strains 
Legend
A. Total RNA extracted from generated transgenic parasite lines (dsENOl, 
dsEN02, dsGFP) and parental strains (RHAHX) were subjected to RT-PCR to 
detect ROP1 and EN 02  expression in mRNA level. The amount o f each 
sample was quantified using spot densitometry of AlphaEase software.
B. RNA extracted from generated transgenic parasite lines dsEN02P, and 
parental strains PLKAHX were subjected to RT-PCR to detect ROP1 and 
EN 02  expression in mRNA level.
C. Western blot analysis was performed using lysate extracted from tachyzoites 
o f the transgenic parasite lines (dsENOl, dsEN02, dsGFP) as well as lysate 
from the parental strains (RHAHX). The blot was treated with specific 
polyclonal antibodies against EN02 (upper panel) and ENOl (middle panel). 
Anti-LDHl antibody was also used to confirm that comparable amount of 
sample were loaded (lower panel).
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Figure 3.5 
Gene expression in transgenic strains 
Legend (continue)
D. Western blot analysis showed the decreasing EN 02 expression level 
dsEN02 strains after transformation. LDH1 signals were also detected 
normalize loading amount.
Lane 1: RHAHX 
Lane 2: dsGFP
Lane 3: dsEN02 after 11 passages 
Lane 4: dsEN02 after 9 passages 
Lane 5: dsEN02 after 6 passages 
Lane 6: dsEN02 after 3 passages 
Lane 7: dsENOl
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Figure. 3.5 
Gene expression in transgenic strains
A. RH RT-PCR
RHAHX dsGFP dsENOl dsEN02
550 bp EN 02
500 bp ROP1
B. PLK RT-PCR
ROP1 EN02
PLKAHXdsEN02P PLKAHX dsEN02P
500 bp 550 bp
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C. Western blot
dsENOl dsEN02 dsGFP RHAHX
48 kDa
EN 02
37 kDa
LDH1
48 kDa EN01
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D. Passage differences
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3.5 The localization of enolase
Immunofluorescence assay was performed to monitor the subcellular localization 
o f enolase in the parental type strain RHAHX, as well as in the generated transgenic 
strains. In addition to EN02 (rhodamine-labeled secondary antibody) detection, we also 
monitored the localization of surface antigen 1 (SAG1 or P30), which is on the 
membrane o f tachyzoites (Fluorescein isothiocyanate (FICT)-labeled secondary antibody, 
green). Merging with nuclei stained (4’, 6 diamidino-2-phenylindole (DAPI), blue) image, 
we detected that the EN02 signal is localized in the cytosol and nuclei, similar to 
previous report on the localization of enolase (Fig. 3.6). In order to estimate the 
expression level of EN02 protein, the intensity of the fluorescence signal o f the parental 
and transgenic tachyzoites were quantified and normalized with reference to the 
background fluorescence signal. The ratio of the EN02 signals from the tachyzoite 
parasite lines over those from the parental was calculated and plotted for each parasite 
line. We detected that the EN02 signal did not change significantly in the strain dsENOl 
or dsGFP when compared to the parental RHAHX strain. However this signal was 
attenuated in the strain dsEN02, indicating the efficiency and specificity of the dsRNA 
induced enolase knockdown effects. Furthermore, in these transgenic parasite strains, 
EN02 signal was observed in both nucleus and cytosol of the parasites, suggesting that 
dsRNA induced RNAi does not affect the localization of EN02 protein.
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Figure 3.6 
Localization of E N 02  
Legend
A. Parasites o f Parental strain RHAHX and transgenic strain dsEN02 are 
subjected to immunofluorescence assay. DAPI was used to label the nucleus 
of parasites (blue). FITC-labeled goat anti-mouse IgG was used to show the 
SAG1 localized on the membrane of T. gondii (green). Rodamine-labeled goat 
anti-rabbit IgG was used to reveal the localization o f EN 02 (Red).
B. Normalized fluorescence values o f EN 02 signals for the parasite lines under 
tachyzoite culture conditions.
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Figure 3.6
Localization of E N 02
DAPI (Nucleus) EN02 SAG1+EN02 DAPI+EN02
dsEN02
B.
RHA HX dsGFP dsENOl dsEN02
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3.6 Phenotypic analysis of transgenic parasite strains
We would expect that the knockdown of enolase might affect the growth of T. 
gondii. The multiplication rates of the transgenic strains as well as the parental strain 
were thus monitored. Since T. gondii proliferates by a synchronic unique binary division, 
the number o f parasites per vacuole could reflect the division rate. Following trypan blue 
staining to evaluate the parasite viability, we used 10,000 viable parasites of each strain, 
including dsENOl, dsEN02 and RHAHX, to infect confluent HFF monolayers. The 
parasites were allowed to invade the host cells for 1 hour, and then non-attached or dead 
parasites were removed by rinsing with fresh media. At 24 hours and 48 hours 
post-infection, we counted the numbers of parasites within independent vacuoles 
(between 150 -  200 vacuoles) The fractions of vacuoles containing 1-, 2-, 4-, 8-, 16 or 2" 
parasites were caculated in order for comparing the growth distribution o f tested parasite 
strains as shown in Figure 3.7. There was no significant difference between the transgenic 
strains dsENOl, dsEN02 and the parental strain RHAHX, indicating that the suppression 
of expression of ENOl and EN02, two isoforms of enolase, did not affect the growth of T. 
gondii, at least in the stage o f tachyzoite.
Plaque formation assay was also employed to monitor the overall proliferation 
ability o f the generated transgenic strains dsENOl, dsEN02, dsGFP as well as the 
parental strain RHAHX. Approximately 5,000 viable parasites were used in the infection 
o f HFF monolayers. After changing the medium at 1 hour post-infection, the cells were 
incubated in tachyzoite culture condition for; 6 days. The plates were stained and the
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number and sizes o f plaques were monitored. No significant differences in the numbers and 
sizes o f formed plaques were detected in the transgenic strains dsENOl ( 6 8  formed 
plaques), dsEN02 (73 formed plaques) when compared with the parental strain RHAHX 
(77 formed plaques). This result further verified that inhibition o f enolase expression does 
not reduce the growth and proliferation ability of T. gondii, at least in the RH strain.
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Figure 3.7 
Parasite growth and replication 
Legend
The fraction distribution of vacuole size (number of parasites in each vacuole) was 
determined at 24 hours (A) and 48 hours (B) after infection with the parental and 
transgenic parasite lines grown under tachyzoite culture conditions. About 150 vacuoles 
were counted for each strain at 24-hour time point, and about 200 were counted at 
48-hour. The expression of EN02 and LDH1 of the strains used at that time point were 
shown by western blot (C).
9 9
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Figure 3.7 
Parasite growth and replication
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c. dsENOl dsEN02 RHAHX
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CHAPTER 4 
DISCUSSION
Enolase is one of the essential enzymes in the processes o f both glycolysis and 
gluconeogenesis. In T. gondii, the stage-specific expression pattern o f  two isoforms of 
enolase (ENOl and EN02), suggests that the activity and effectiveness of this enzyme 
are important for the tachyzoite and bradyzoite. Stage differentiation and encystation of T. 
gondii involves the coordinated expression of several genes. A series o f induction and 
suppression of gene expression are observed during the process as developmental 
dynamics. It is not surprising to propose the involvement of enolase expression in the 
process of stage differentiation between tachyzoite and bradyzoite. Although classical 
nuclear localization signal is not found in ENOl and EN02 primary sequences, their 
nuclear targeting can be enabled by a NLS in their tertiary structures (Sessler and Noy 
2005), or be mediated by importin-independent pathways (Gorlich and Kutay, 1999). 
Nuclear localization of ENOl and EN 02 proteins suggests other functions such as 
regulation o f gene expression o f this enzyme in addition to its contribution to the 
metabolism of the parasites (Johnstone et al., 1992;Ghosh et al., 1999). Thus, study on 
the function of this enzyme, particularly silencing o f its expression, would be of great 
interest and be important to provide potential drug targets for the treatment to 
toxoplasmosis.
102
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Transient transformation and silencing of enolase
Previous studies by our group have confirmed that dsRNA can be used as a 
powerful tool to repress the steady-level expression of T. gondii genes including UPRT 
and LDH  (Al-Anouti et al., 2003; Al-Anouti et al., 2004). We first used dsRNA 
homologous to ENOl and EN 02  genes to silence the expression of enolase in T. gondii. 
From RT-PCR and western blot analysis, I clearly demonstrated the efficiency and 
specificity o f synthetic dsRNA in down-regulating enolase expression. Silencing of 
EN 02  did not affect to the expression o f ENOl and GFP, and vice versa. Although, we 
did not determine whether siRNA was produced, we suspect that siRNA produced from 
dsRNA can function as miRNA and can inhibit expression of non-perfect-matching genes 
in translational level (Doench et al., 2003). Both siRNA and miRNA gene silencing 
pathway share similar partners such RNaselll (Dicer) and Argonaute family proteins and 
are likely to be present in T. gondii, although miRNA pathway has not been reported in T. 
gondii. Though we cannot state definitely that miRNA as well as siRNA is responsible 
for the gene silencing, we can conclude that the difference between ENOl and EN 02  is 
sufficient (65.8%) to obtain specific gene silencing.
Stable transformation and transgenic line generation
To circumvent the disadvantage of transient transformation, we used constructed 
plasmids and T. gondii strain RHAHX to generate transgenic parasite lines. We also
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attempted to generate the transgenic parasites lines using PLKAHX. We could not 
produce the lines, except one expressing EN 02  homologous dsRNA, naming dsEN02P. 
Parasite strains RHAHX, PLKAHX are different in growth and replication rate. Failure to 
generate transgenic parasites lines expressing ENOl homologous dsRNA might be due to 
the slow proliferation ability of the PLKAHX strain, which renders the electroporated 
parasites hard to propagate under selection. Another possibility is the transformation 
stability o f this plasmid is low in PLKAHX strain, or the expression of ENOl is important 
for the growth of PLKAHX strain.
We also found that, the expression of EN02 in the dsEN02 parasites was gradually 
lowered during parasite passages and became stable at -40%  of the steady state level of 
the untransformed parasites. One of the possibilities is that the expression of dsRNA was 
increasing after transformed plasmid stably integrated into parasite genome, leading to 
the increasing inhibition of target gene expression induced by dsRNA. It is also possible 
that, after plasmid transformation, untransformed parasites and those with unstable 
transformation were able to survive under selection at first, but were killed gradually 
under selection pressure. We attempted to purify the transformed parasites by limiting 
dilution, but all five single clonal strains did not show any EN 02 knockdown after three 
passages. Probably more passages of the transformed parasites would be required to 
enhance the dsRNA inhibition effects. Monitoring the amount o f dsRNA expressed by 
quantitative real-time RT-PCR may provide useful information about this question.
PCR using DNA extracted from transgenic parasite lines showed the presence of
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transgenes in these generated cell lines. However, it was difficult to distinguish whether 
these transgenes were integrated into the genome or maintained as episomes. To have 
clear evidences of plasmid integration or episomal maintenance, we need to perform a 
plasmid rescue experiment. Briefly we would extract total DNA from the parasites and 
use it to transform competent E. coli cells. Only episomal DNA will have the 
transforming plasmid features to confer ampicillin resistance. Also, restriction 
endonuclease digestion followed by Southern blot analysis would address this question.
Phenotypic study of enolase knockdown
The ratio of vacuoles containing different numbers o f T. gondii in total vacuoles 
showed the proliferation ability of the parasites, and plaque assay reflected both invasion 
ability and proliferate ability. Results o f both methods indicated knockdown o f EN02 
expression does not affect the growth of the parasites. As the glycolysis is considered to 
be important for the growth and development of T. gondii, and enolase is an essential part 
of glycolysis process, these results are quite surprising to some degree. One of the 
possibilities is that T. gondii has plenty amount of EN 02 expression, and the lefeover 
EN02 in dsEN02 strain is sufficient for the survival of the parasites. Gene targeting of 
EN02 gene by homologous recombination (knockout or knockin) or expression of 
inactive EN 02 to produce dominant-negative mutant may help to resolve the role of 
EN02 in T. gondii. It is also possible that other genes, enzymes or metabolic pathways 
have taken over to compensate for the reduction of EN02 expression. To have a global
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view of the gene expression, we need to perform microarrays to classify affected genes. 
Moreover, we could use metabolic inhibitors, specific to the enzymes of the glycolysis 
pathway to survey the drug sensitivity in the parental and transgenic parasites. Other 
metabolism pathways, including TCA cycle and anaerobic respiration may provide 
required NADH and subsequent ATP for the survival o f the parasites when glycolysis is 
suppressed. Additionally, fatty acids and amino acids can be oxidized to produce 
acetyl-CoA, pyruvate and other metabolites required in these processes instead of 
glycolysis pathway. Inhibition of these pathways may provide adequate insight into the 
metabolism system of the transgenic parasites and put forward essential information for 
this study.
Future work
In this study, we used dsRNA-induced gene silencing to lower the expression of 
enolase isoforms, ENOl and EN02 in Toxoplasma gondii. Two transgenic parasite lines 
with attenuated enolase expression dsENOl and dsEN02 were successfully generated. 
We found that, although EN02 expression was reduced, it did not affect the growth 
ability o f T. gondii strain RH. Future work could be directed to study the effects of 
enolase knockdown in the stage of bradyzoite as well as the process o f stage conversion. 
Moreover, we would like to investigate the reason for unaffected growth o f T. gondii with 
lowered enolase expression. Inhibitors o f Krebs cycle and anaerobic respiration as well as 
fatty acid and amino acid oxidation pathway will be used to elucidate the possible
106
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
pathway utilized by the parasites to compensate the suppression o f glycolysis. 
Additionally, extra roles of T. gondii enolase isoforms will be another target o f upcoming 
study. Protein and chromatin immunoprecipitation can provide useful information about 
proteins and DNA bound with enolase in the nuclei, and grant essential information about 
the functions of enolase.
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APPENDICES
Appendix I
General buffers and solutions used in the study
Buffer or solution Constituents
Blocking solution for western blot 5 g slim milk powder in 100 ml TBS
Electroporation buffer
120 mM M KC1, 0.15 mM CaCl2, 10 mM 
K2HPO4/KH2PO4 , pH 7.6, 25 mM HEPES, 
pH 7.6, 2 mM EDTA, 5 mM MgCl2
TBS 125 mM NaCl, 25 mM Tris
TBST 0.2% Tween 20 in TBS
6  x DNA gel loading buffer 0.25% (w/v) bromophenl blue, 0.25% (w/v) 
xylene cyanol FF, and 40% (w/v) sucrose in 
water
Dulbecco’s phosphate-buffered saline 
(DPBS)
PBS buffer supplemented with 0.1 g/1 Ca+2
Luri Bertani broth (LB broth)
10 g/1 tryptone, 5 g/1 yeast extract and, 0.17 
M NaCl. The broth is sterilized by 
autoclaving for 15 min.
Tris EDTA (TE) 10 mM Tris, pH 8.0, and 1 mM EDTA
Tris-Acetate-EDTA (TAE) 40 m Tris-acetate and 1 mM EDTA
Phosphate-buffered saline (PBS)
0.14 M NaCl, 2.7 mM KC1, 10 mM 
Na2H P 0 4 and 1.76 mM KH2P 0 4 KH2P 0 4, 
pH 7.4
9% acrylamide/bisacrylamide (37.5:1), 0.39
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SDS-PAGE Resolving gel M Tris, pH 8 .8 , 0.1% SDS, 0.1% APS and 
0.04% TEMED
SDS-PAGE Stacking gel
5% acrylamide/bisacrylamide (37.5:1), 
0.125 M Tris, pH 6 .8 , 0.1% SDS, 0.1% APS 
and 0.1% TEMED
SDS-PAGE loading 25mM Tris, pH 6 .8 , 2% SDS, 0.1% 
Bromophenol Blue, 720 mM 
2 -mercaptoethanol and 1 0 % glycerol
Tris-glycine 25 mM Tris, pH 8.3, 196 mM glycine and 
0.1% SDS
Transfer buffer for western blot 25 mM Tris, 192 mM glycine, 20% 
methonal
Protein Lysis buffer 300 mM NaCl, 20 mM Tris-HCl, 1 mM 
DTT, 0.5 mM PMSF, pH7.5,
Genomic DNA extraction buffer 100 mM EDTA, 10 mM Tris-HCl, pH 8.0 
and 1% SDS
Miniprep solution I 50 mM glucose, 25 mM Tris-HCl, pH 8.0
Miniprep solution II 0.2 N NaOH, 1% SDS
Miniprep solution III 3 M NaOAc, pH 5.2
Ponceau Staining solution 0.1% ponceau in 5% acetic acid solution
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Appendix II 
Oligonucleotide prim ers used in the study
Names Sequences
BamHI 5' pTUB8 CCGGATCCGTCGACGGTATCGATAAGC
Nsil 3’pTUB8 CTCATGC ATTTTGTCG
HXGPRT forward ATGGCGTCCAAACCCATTGAA
HXGPRT  reverse ACCGGTGTCGACGTCCTC
5'HXcassatte CCAGAATTCAAGATCCGATCTTGC
3’HXcassette CCAGAATTCTGTCACTGTAGCCTG
5 ’ENOx ATGGTGGTTATCAAGG
3 'ENOx CCAACGGGAGCGATC
EcoRITgArg5'end T GG A ATTCCCCGC AGTATTT CGC A A AT G
EcoRIT g Arg3 'end CGGAATTCGCTTCGCCACTGAGGTGAG
OligodT TTTTTTTTTTTTTTTTTT
EcoRIdTTAIL AAGAATTCTTTTTTTTTTTTTTTTTT
llo n X E N O x TAATACGACTCACTATAGGATGGTGGTTATCAAGG
T7on3 ’ENOx TAATACGACTCACTATAGGCCAACGGGAGCGATC
l lo n y R O P TAATACGACTCACTATAGGGGAACATGGGCCACAGG
llo n V R O P TAATACGACTCACTATAGGCGCCGAAAGCGTCTCTG
T7-5GFPmut2 AAGAATTCTAATACGACTCACTATAGGAGAAGAACTTTCAC
T7-3GFPmut2 AAG A ATT CTAATACG ACT C ACTATAGGTCT GCTAATT G AA
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Appendix III
Nucleotide sequence of constructed plasmids used in the study
All the constructed plasmids were generated from commercial plasmid 
pBluescript SK+. The primers used for each DNA fragments are indicated by arrows.
Kpnl
Ampicillih R e s is ta n c e  il>l«v
Tul>8 p io m o te i
HXGPRT
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p(TUB8)2EN01-HX
The TUB 8  promoter as well as followed ENOl DNA fragment and the opposite 
TUB8  promoter were used to replace 653-719nt (Kpnl-BamHT) o f pBluescript SK+. And 
HXGPRT expression cassette was inserted at the SacII site (747 nt) o f pBluescript SK+.
Nucleotide sequence o f TUB8  promoter (515bp)
Kpnl
GGTACCGGGC CCCCCCTCGA CGGTTATCGA TAAGCTTAAC CACAAACCTT 
GAGACGCGTG TTCCAACCAC GCACCCTGAC ACGCGTGTTC CAACCACGCA 
CCCTGAGACA CATGTTCTAA CCACGCACCC TGAGACGCGT GTTCTAACCA 
CGCACCCTGA GACGCGTGTT CAAGCTTGCC TGCATTGGGT GCGGTTGGTG 
ATCCTGGTTG GACCGGTGGA GATGCGCGCG CACGAAGGGG ATGTGTCAGA 
AACATTTTGT TTGTTCTCTG TGAACTTTTA GATGTGTTAA AGGAGGAGAA 
TATTAGCAGA GAGTCCTCCT TGTTCCATTC TCTCTTGAAT TTCGCCCTTT 
CCTTCTCTTT GCGAGTGTGG TAGAGAACAA GCACTCGTTC GCCGTCCCTG 
ACGACGCAAC CCGCGCAGAA GATCCACCAA ACGGTGTTAC ACAATCACCT 
TGTGTGAAGT TCTTGCGGAA AACTACTCGT TGGCATTTTT TCTTGAATTC 
CCTTTTTCG A CAAAA
Nucleotide sequence of ENO l fragment (542bp)
ATGGTGGTTA TCAAGGACAT CGTTGCACGC GAGATTTTGG ATTCTCGCGG 
CAATCCCACA ATTGAAGTTG ATGTATCAAC TGAAGGAGGT GTCTTCCGAG 
CTGCGGTTCC TAGTGGAGCG TCTACGGGTA TTTATGAGGC TCTGGAGTTG 
CGCGATAAAG ATCCGAAACG GTACTTGGGG AAAGGCGTGC TGAACGCTGT 
AGAGATTGTC CGACAGGAAA TCAAGCCAGC ATTGCTGGGC AAAGATCCGT 
GTGATCAGAA AGGTATTGAT ATGCTTATGG TGGAGCAGCT GGACGGAACA 
AAAAACGAGT GGGGCTATTC CAAGTCAAAG CTAGGTGCAA ATGCCATTTT 
GGGCGTGTCG ATAGCTTGCT GCCGAGCAGG AGCAGCATCA AAAGGCCTAC 
CACTATACAA ATACATCGCT ACACTTGCAG GGAAAACGAT CGATAAGATG
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R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
GTTATGCCTG TACCGTTTTT CAATGTTATC AATGGAGGCG AACATGCAGG 
CAATGGCTTG GCTCTTCAAG AATTCCTGAT CGCTCCCGTT GG
Nucleotide sequence of reverse TUB8  promoter (505bp)
TTTTGTCGAA AAAGGGAATT CAAGAAAAAA TGCCAACGAG TAGTTTTCCG 
CAAGAACTTC ACACAAGGTG ATTGTGTAAC ACCGTTTGGT GGATCTTCTG 
CGCGGGTTGC GTCGTCAGGG ACGGCGAACG AGTGCTTGTT CTCTACCAC 
ACCGCAAAGA GAAGGAAAGG GCGAAATTCA AGAGAGAATG GAACAAGGAG 
GACTCTCTGC TAATATTCTC CTCCTTTAAC ACATCTAAAA GTTCACAGAG 
AACAAACAAA ATGTTTCTGA CACATCCCCT TCGTGCGCGC GCATCTCCAC 
CGGTCCAACC AGGATCACCA ACCGCACCCA ATGCAGGCAA GCTTGAACAC 
GCGTCTCAGG GTGCGTGGTT AGAACACGCG TCTCAGGGTG CGTGGTTAGA 
ACATGTGTCT CAGGGTGCGT GGTTGGAACA CGCGTGTCAG GGTGCGTGGT 
TGGAACACGC GTCTCAAGGT TTGTGGTTAA GCTTATCGAT AACCGTCGAC 
GGATCC
BamHl
Nucleotide sequence of HXGPRT Cassette (1889 bp)
SucH
CCGCGGAAGA TCCGATCTTG CTGCTGTTCG CGTCCCAGTA GCGTCCTGTC 
GGCCGCGCCG TCTCTGTTGG TGGGCAGCCQ CTACACCTGT TATCTGACTG 
CCGTGCGCGA AAATGACGCC ATTTTTGGGA AAATCGGGGA ACTTCATTCT 
TTAAAAGTAT GCGGAGGTTT CCTTTTTCTT CTGTTCGTTT CTTTTTCTCG 
GGTTTGATAA DCGTGTTCGA TGTAAGCACT TTCCGTCTCT CCTCCGTGCT 
TTGTTCGACA TCGAGACCAG GTGTGCAGAT CCTTCGCTTG TCGATCCGGA 
GACGCGTGTC TCGTAGAACC TTTTCATTTT ACCAACGGCA GTGCGGAGCA 
CTGCTCTGAG TGCAGCAGGG ACGGGTGAAG TTTCGCTTTA GTAGTGCGTT 
TCTGCTCTAC GGGGCGTTGT CAGATCCAAA ATGGCGTCCA AACCCATTGA 
AGACTACGCC AAGGGCAACG GCCGTATTGA GCCCATGTAT ATCCCCGAGA 
ACACCTTCTA GAACGCTCAT GACTTTCTTG TGCCCCCCCA CTGCAAGCCC 
TACATTGACA AAATCCTCCT CCCTCGTGGA TTGGTCAAGG AGAGAGTTGA 
GAAGTTGGCG TATGACATCC ACAGAACTTA GTTCGGCGAG GAGTTGCACA
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TCATTTGCAT CCTGAAAGGC TCTCGCGGCT TCTTCAACCT TCTGATCGAG 
TACCTTGCCA CCATACAGAA GTAGAATGGT CGTGAGTCCA GCGTGCCCCC 
CTTCTTCGAG CACTATGTCC CCCTGAAGTC CTACCAGAAC GACAACAGCA 
CAGGCCAGCT TACCGTCTTG AGCGACGACT TGTCAATCTT TCGCGACAAG 
CACGTTCTGA TTGTTGAGGA GATCGTCGAG ACCGGTTTCA ACCTCACCGA 
GTTCGGTGAG CGCCTGAAAG CCGTCGGTCC CAAGTCGATG AGAATCGCCA 
CCCTCCTCGA GAAGCGCACA GATCGCTCCA ACAGCTTGAA GCCGGCCGAG 
TTCGTCGGCT TCAGCATTGA AGAGGTCTGG ATCGTTGGTT GCTGCTACGA 
CTTCAACGAG ATGTTCCGCG ACTTCGAGCA CGTCGCCGTC CTGAGCGACG 
CCGCTCGCAA AAAGTTCGAG AAGTAAACCC TGCATAGCCC TACAGAAGCT 
GCCCGTCTCT CGTTTTCCTC TCTTTTCGGA GGGATCAGGG AGAGTGCCTC 
GGQTCGGAGA GAGCTGACGA GGGGGTGCCA GAGACCCCTG TGTCCTTTAT 
CGAAGAAAAG GGATGACTCT TCATGTGGCA TTTCACACAG TCTCACCTCG 
CCTTGTTTTC TTTTTGTCAA TCAGAACGAA AGCGAGTTGC GGGTGACGCA 
GATGTGCGTG TATCCACTCG TGAATGCGTT ATCGTTCTGT ATGCCGCTAG 
AGTGCTGGAC TGTTGCTGTC TGCCCACGAC AGCAGCCAAC TTTCCTTCTA 
TGCACTTGCA GGATGGTGCA GCGCAAACGA CGGAGAGAAA GGAGCACCCT 
CTCAGTTTCC CTACGATGTG CTGTCAGTTT CGACTCTTCA CCGCGAACGA 
TTGGCGATAC GTCTCTGTTG ACTTGTTAGG CTCCGACCAC GAAGCTCCCT 
T AACT A A AT A AGCCGCGACA CCTAAGTGTA CACCATTTGC AGATCGATAA 
TCTGCGACCG CTGAATCCGT CCAGATCAGT AAAACCGCAC CACCTAAGTG 
TAAACCTTGT TTAGGTCGAT AAAATGCTAC CAACCCCCAC CCACAATCGA 
GCCTTGAGCG TTTCTGCGCA CGCGTTGGCC TACGTGACTT GCTGATGCCT 
GCCTCTGGCC ATTCATCCAG TCAGTGCGCA TAAAAATGTG GACACAGTCC 
GGTTGACAAG TGTTCTGGCA GGCTACAGTG ACACCGCGG
Sacll
p(TUB8)2£7\0 2 -H X
Similar to p lT U B ^E N O J-H X except ENOl fragment replaced by EN 02  fragment. 
Nucleotide sequence o f EN02 fragment (542bp)
ATGGTGGCCA TCAAGGACAT CACTGCTCGT CAGATCCTCG ACTCCCGAGG 
AAACCCGACC GTCGAGGTTG ACTTGTTGAC CGATGGCGGC TGCTTCCGTG 
CCGCTGTCCC CAGCGGCGCA TCCACTGGCA TCTACGAGGC GCTTGAGCTC 
CGTGACAAGG ACCAAACTAA GTTCATGGGC AAGGGTGTGA TGAAGGCCGT 
GGAGAACATC CACAAGATTA TCAAGCCGGC GCTTATTGGC AAGGACCCGT 
GCGACCAGAA GGGTATTGAC AAGCTGATGG TCGAGGAGCT CGATGGAACT 
AAGAACGAGT GGGGCTGGTG CAAGTCGAAG CTCGGCGCGA ACGCGATCCT
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GGCCGTCTCG ATGGCTTGCT GCCGCGCCGG CGCTGCTGCC AAGGGCATGC 
CCCTGTACAA GTACATTGCC ACTTTGGCTG GAAACCCGAC AGACAAGATG 
GTAATGCCCG TCCCGTTCTT CAACGTCATC AACGGCGGCT CCCACGCAGG 
CAACAAGGTC GCGATGCAGG AGTTCATGAT CGCCCCCGTC GG
p(TUB8)2GFP-lZX
Similar to p(7\JB8)2EN01-HXexcept ENOl fragment replaced by GFP fragment. 
Nucleotide sequence of GFP fragment (533bp)
A G G A G A A G A A CTTTTCACTG GAGTTGTCCC AATTCTTGTT GAATTAGATG 
GCGATGTTAA TGGGCAAAAA TTCTCTGTCA GTGGAGAGGG TGAAGGTGAT 
GCAACATACG GAAAACTTAC CCTTAAATTT ATTTGCACTA CTGGGAAGCT 
ACCTGTTCCA TGGCCAACAC TTGTCACTAC TTTCGCGTAT GGTCTTCAAT 
GCTTTGCGAG ATACCCAGAT CATATGAAAC AGCATGACTT TTTCAAGAGT 
GCCATGCCCG AAGGTTATGT ACAGGAAAGA ACTATATTTT ACAAAGATGA 
CGGGAACTAC AAGACACGTG CTGAAGTCAA GTTTGAAGGT GATACCCTTG 
TTAATAGAAT CGAGTTAAAA GGTATTGATT TTAAAGAAGA TGGAAACATT 
CTTGGACACA A A AT GG A ATA CAACTATAAC TCACATAATG TATACATCAT 
GGCAGACAAA CCAAAGAATG GAATCAAAGT TAACTTCAAA ATTAGACACA 
ACATTAAAGA TGGAAGCGTT CAATTAGCAG ACC
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Appendix IV
Nucleotide sequence of other constructed plasmids
All the constructed plasmids were generated from commercial plasmid 
pBluescript SK+. The primers for each DNA fragment are indicated by arrows.
Kpnl
Tiil>8tet4 T i ib 5tet7 |>i om otei \ EcoRI
Ai <jon»nite
TubStetJ |>i om otei
HX Cos s err e
S.ICll
pT8t4ArgoT8t4-.HX
The TUB8tet4 promoter as well as followed Argonaute DNA fragment and the 
opposite TUB8tet4 promoter were used to replace 653-719nt (Kpril-BamHl) of 
pBluescript SK+. And HXGPRT expression cassette was inserted at the SacII site (747 nt)
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of pBluescript SK+.
Nucleotide sequence of Tub8tet4 promoter (598 bp)
Kpnl
GGTACCGGGC CCCCCCTCGA CGGTATCGAT AAGCTTAACC ACAAACCTTG 
AGACGCGTGT TCCAACCACG CACCCTGACA CGCGTGTTCC AACCACGCAC 
CCTGAGACGC GTGTTCTAAC CACGCACCCT GAGACGCGTG TTCTAACCAC 
GCACCCTGAG ACGCGTGTTC AAGCTTGCCT GCATTGGGTG CGGTTGGTGA 
TCCTGGTTGG ACCGGTGGAG ATGCGCGCGC ACGAAGGGGA TGTGTCAGAT 
CCCTATCAGT GATAGAGACT CGAGTCTATC ACTGATAGGG ATGTCGAGTC 
TATCACTGAT AGGGATGTCG AGTCTATCAC TGATAGGGAT GTCGAGAACA 
TTTTGTTTGT TCTCTGTGAA CTTTTAGATG TGTTAAAGGC GGCGAATATT 
AGCAGAGAGT CCTCCTTGTT CCATTCTCTC TTGAATTTCG CCCTTTCCTT 
CTCTTTGCGA GTGTGGTAGA GAACAAGCAC TCGTTCGCCG TCCCTGACGA 
CGCAACCCGC GCAGAAGACA TCCACCAAAC GGTGTTACAC AATCACCTTG 
TGTGAAGTTC TTGCGGAAAA CTACTCGTTG < GCATTTTTTC TTGAATTC
EcoRI
Nucleotide sequence of Argonaute DNA fragment (861 bp)
CCCGCAGTAT TTCGCAAATG TTATGTCCAA AGTCAACATG AAGTTGCAAG 
GAGTGAATCA AACCCTCGAG GCGGATATAA TAAAGCAAGA AATCGGAACG 
GACAAGAGCA CATTGGTCTT GGCGGTAGAA ACATCATTCT TTGCAAATCC 
GACTAAAACT TCTCCCCCGC CGACAGCGCC CATTGTGTGT GCGTGTACGG 
GAAACATGGA CGATGATCTT GGCGCGTTCG GTCATGCTGT TTGCGTTGAA 
TCGCGAAAGC ATCCCATAGT GACTGATATT GGGAGTATGT TTAAAACTAT 
TCTCTCCTAT CGAAAGACAA CGAAAAACTG GCCGGCGCGA ATCATCTACC 
TTCGATCTGC CACTACAGAA GCACACTTCC CTCTTGTATT GGCCGGCGAA 
ATCCGTGCGA TCGAAGAATT ATATGTTCGT GAAAACCGTT CAAAACCTCG 
AATCCTCGCC GTAGCAGTGC AAAGGCGACA GCAAACACGT TTATTCCCTA 
CGAAGGAGAT GCAGGCTCAG GGAAACAATC TGCCAGCAGG GTTCTTGCTT 
GCGAATAGTC TGCAACATCC AGGGCACTTC CGAAATTTCT TGTTGATCTC 
ACACAAAGCA CTCCAGGGAA CAGCGCGCCC AACAAGGTAT TACATTTTAA 
GAGACGATGC GAACCGCGAC AT GG A A A AAG TTGCCCAGCT GATGTACTCT 
CTGTGCCATG TGTACGGTCG CTGCCAGCGA GCGGTCTCCA TTCCCGCTCC 
CCTGTACTAC GCCGAGCTGC TGGCGGCAAG AGCTCAAAGC TACATGAAGG 
TTGGCATGCG TAGAGAAAGA AATATAGATA TTGACGATCT TTCTCACCTC
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AGTGGCGAAGC
Nucleotide sequence o f Reverse Tub8tet4 promoter (589 bp)
EcoRI
GAATTCAAGA AAAAATGCCA ACGAGTAGTT TTCCGCAAGA ACTTCACACA 
AGGTGATTGT GTAACACCGT TTGGTGGATG TCTTCTGCGC GGGTTGCGTC 
GTCAGGGACG GCGAACGAGT GCTTGTTCTC TACCACACTC GCAAAGAGAA 
GGAAAGGGCG AAATTCAAGA GAGAATGGAA CAAGGAGGAC TCTCTGCTAA 
TATTCGCCGC CTTTAACACA TCTAAAAGTT CACAGAGAAC AAACAAAATG 
TTCTCGACAT CCCTATCAGT GATAGACTCG ACATCCCTAT CAGTGATAGA 
CTCGACATCC CTATCAGTGA TAGACTCGAG TCTCTATCAC TGATAGGGAT 
CTGACACATC CCCTTCGTGC GCGCGCATCT CCACCGGTCC AACCAGGATC 
ACCAACCGCA CCCAATGCAG GCAAGCTTGA ACACGCGTCT CAGGGTGCGT 
GGTTAGAACA CGCGTCTCAG GGTGCGTGGT TAGAACACGC GTCTCAGGGT 
GCGTGGTTGG AACACGCGTG TCAGGGTGCG TGGTTGGAAC ACGCGTCTCA 
AGGTTTGTGG TTAAGCTTAT CGATACCGTC GACGGATCC
BamHl
^T S tlA rgoT m -H X
Similar to pT8t4^rgoT8t4-//A except first Tub8tet4 promoter replaced by Tub5tet7 
promoter.
Nucleotide sequence o f Tub5tet7 (682bp)
Kpnl
GGTACCGGTC GACGGTATCG ATAAAGCTTG ATGGCGATGC ATGTCCCGCG 
TTCGTGAAAT TCTCTGCATC AGCGGAGTGA TCAGGAATCA TCGTCTCAGC 
GGGATGACGT TGCGGAGCAG GCCGGCTCGC GGTGGGCAGT CAGATGCCGA 
AGGCGTAACT CAGGACGGCT TGCGCTCATC GCAGAACAGG GGTGGTGCCT 
GCATTGGGTG CGGTTGGTGA TCCTGGTTGG ACCGGTGGAG ATGCGCGCGC 
ACGAAGGGGA TGTGTCAGAT CCCTATCAGT GATAGAGACT CGAGTCTATC 
ACTGATAGGG ATGTCGAGTC TATCACTGAT AGGGATGTCG AGTCTATCAC
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TGATAGGGAT GTCGAGTCTA TCACTGATAG GGATGTCGAG TCTATCACTG 
ATAGGGATGT CGAGTCTATC ACTGATAGGG ATGTCGAGAA CATTTTGTTT 
GTTCTCTGTG AACTTTTAGA TGTGTTAAAG GCGGCGAATA TTAGCAGAGA 
GTCCTCCTTG TTGGATTCTC TCTTGAATTT CGCCCTTTCC TTCTCTTTGC 
GAGTCTCGTA GAGAACAAGC ACTCGTTCGC CGTCCCTGAC GACGCAACCC 
GCGCAGAAGA CATCCACCAA ACGGTGTTAC ACAATCACCT TGTGTGAAGT 
TCTTGCGGAA AACTACTCGT TGGCATTTTT TCTTGAATTC
EcoRI
K|>nl
Tul>8tet4Tiil>5tet7 pi omotei
EcoRI
Tul>8tet4 |»i omotei
EcoRICAT
l>30 11 pi omotei
N s il
pT8t4^r^oT8t4-p30/HC47’
The TUB8tet4 promoter as well as followed Argonaute DNA fragment and the opposite
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TUB8tet4 promoter were placed next to Kpnl (653 nt) of pBluescript SK+. And CAT 
expression cassette (p30/ll promoter + CAT gene + p30 3’UTR) was inserted before 
BamHl site (719 nt) of pBluescript SK+.
Nucleotide sequence o f p3 0/11 promoter (518bp)
CTCGAGGTCG ACGGTATCGA TAAGCTTAAC CACAAACCTT GAGACGCGTG 
TTCCAACCAC GCACCCTGAC ACGCGTGTTC CAACCACGCA CCCTGAGACG 
CGTGTTCTAA CCACGCACCC TGAGACGCGT GTTCTAACCA CGCACCCTGA 
GACGCGTGTT CAAGCTTAAC CACAAACCTT GAGACGCGTG TTCCAACCAC 
GCACCCTGAC ACGCGTGTTC CAACCACGCA CCCTGAGACG CGTGTTCTAA 
CCACGCACCC TGAGACGCGT GTTCTAACCA CGCACCCTGA GACGCGTGTT 
CTGCCGCACA ATGTGCECCT GTAGGAAGCT GTAGTCACTG CTGATTCTCA 
CTGTTCTCGG CAAGGGCCGA CGACCGGAGT ACAGTTTTTG TGGGCAGAGC 
CGTTGTGCAG CTTTCCGTTC TTCTCGGTTG TGTCACATGT GTCATTGTCG 
TGTAAACACA CGGTTGTATG TCGGTTTCGC TGCACCACTT CATTATTTCT 
TCTGGTTTTT TGACGAGT
Nucleotide sequence of CAT gene (697bp)
Nsil
ATGCATGAGA A A A A A AT C AC TGGATATACC ACCGTTOATA TATCCCAATC 
CCATCGTAAA GAACATTTTG AGGCATTTCA GTCAGTTGCT CAATGTACCT 
ATAACCAGAC CGTTCAGCTC GATATTACGG CCTTTTTAAA GACCGTAAAG 
AAAAATAAGC ACAAGTTTTA TCCGGCCTTT ATTCACATTC TTGCCCGCCT 
CATGAATGCT CATCCGGAAT TCCGTATGGC AATGAAAGAC GGTGAGCTGG 
TGATATGGGA TAGTGTTCAC CCTTGTTACA CCGTTTTCCA TGAGCAAACT 
GAAACGTTTT CATCGCTCTG GAGTGAATAC CACGACGATT TCCGGCAGTT 
TCTACACATA TATTCGCAAG ATGTGGCGTO TTACGGTGAA AACCTGGCCT 
ATTTCCCTAA AGGGTTTATT GAGAATATGT TTTTCGTCTC AGCCAATCCC 
TGGGTGAGTT TCACCAGTTT TGATTTAAAC GTGGCCAATA TGGACAACTT 
CTTCGCCCCC GTTTTCACCA TGGGCAAATA TTATACGCAA GGCGACAAGG
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TGCTGATGCC GCTGGCGATT CAGGTTCATC ATGCCGTCTG TGATGGCTTC 
CATGTCGGCA GAATGCTTAA TGAATTACAA CAGTACTGCG ATGAGTGGCA 
GGGCGGGGCT TAATTAA
P a d
Nucleotide sequence of p30 3’UTR (317)
TCACCGTTGT GCTCACTTCT CAAATCGACA AAGGAAACAC ACTTCGTGCA
GCATGTGCCC CATTATAAAG AAACTGAGTT GTTCCGCTGT GGCTTGCAGG
TGTCACATCC ACAAAAACCG GCCGACTCTA AATAGGAGTG TTTCGCAGCA
AGCAGCGAAG TTTATGACTG GGTCCGAATC TCTGAACGGA TGTGTGGCGG
ACCTGGCTGA TGTTGATCGC CGTCGACACA CGCGCCACAT GGGTCAATAC
ACAAGACAGC TATCAGTTGT TTTAGTCGAA CCGGTTAACA CAATTCTTGC
CCCCCCGAGG GGGATCC 
BamH
pT5t7/4rg0T8t4-p3O/llC47’
Similar to pT8t44rgoT8t4-p30/llC 4r except first Tub8tet4 promoter replaced by 
Tub5tet7 promoter.
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